Gryphon Digital Mining (GRYP) 10-K 31 Mar 22 2021 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Mar. 16, 2022	Jun. 30, 2021
Document and Entity Information [Abstract]
Entity Registrant Name	Akerna Corp.
Entity Central Index Key	0001755953
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2021
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2021
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Interactive Data Current	Yes
Entity File Number	001-39096
Entity Incorporation State Country Code	DE
Entity Public Float			$ 94.6
Entity Common Stock, Shares Outstanding		32,054,463
Entity Address, Address Line One	1550 Larimer Street
Entity Address, Address Line Two	#246
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80202
Entity Tax Identification Number	83-2242651
City Area Code	(888)
Local Phone Number	932-6537
Document Transition Report	false
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	KERN
Security Exchange Name	NASDAQ
Document Annual Report	true
Auditor Name	Marcum LLP
Auditor Firm ID	688
Auditor Location	Los Angeles, CA

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash	$ 13,934,265	$ 17,840,640
Restricted cash	508,261	500,000
Accounts receivable, net	1,403,774	1,753,547
Prepaid expenses and other current assets	2,383,764	2,458,727
Total current assets	18,230,064	22,552,914
Fixed assets, net	153,151	1,193,433
Investment, net	226,101	233,664
Capitalized software, net	7,311,676	3,925,739
Intangible assets, net	21,609,794	7,388,795
Goodwill	46,942,681	41,874,527
Other noncurrent assets	9,700
Total assets	94,483,167	77,169,072
Current liabilities:
Accounts payable, accrued expenses and other current liabilities	6,063,520	3,188,576
Contingent consideration payable	6,300,000
Deferred revenue	3,543,819	843,900
Current portion of long-term debt	13,200,000	11,707,363
Derivative liability	63,178	311,376
Total current liabilities	29,170,517	16,051,215
Long-term portion of deferred revenue	582,676
Long-term debt, less current portion	4,105,000	3,895,237
Deferred tax liabilities	675,291
Total liabilities	34,533,484	19,946,452
Commitments and contingencies (Note 14)
Stockholders' equity
Preferred stock, par value $0.0001; 5,000,000 shares authorized, 1 share special voting preferred stock issued and outstanding at December 31, 2021 and December 31, 2020
Special voting preferred stock, par value $0.0001; 1 share authorized, issued and outstanding as of December 31, 2021 and December 31, 2020, with $1 preference in liquidation; exchangeable shares, no par value, 309,286 and 2,667,349 shares issued and outstanding as of December 31, 2021 and December 31, 2020, respectively (See Note 4)	2,366,038	20,405,219
Common stock, par value $0.0001; 75,000,000 shares authorized, 31,001,884 and 19,901,248, issued and outstanding at December 31, 2021 and December 31, 2020, respectively	3,100	1,990
Additional paid-in capital	146,027,258	94,086,433
Accumulated other comprehensive loss	61,523	(91,497)
Accumulated deficit	(88,508,236)	(57,179,525)
Total equity	59,949,683	57,222,620
Total liabilities and equity	$ 94,483,167	$ 77,169,072

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	1	1
Preferred stock, shares outstanding	1	1
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	31,001,884	31,001,884
Common stock, shares outstanding	19,901,248	19,901,248
Exchangeable Shares
Preferred stock, shares issued	309,286	2,667,349
Preferred stock, shares outstanding	309,286	2,667,349
Preferred stock, no par value	$ 0	$ 0
Special Voting Preferred Stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1	1
Preferred stock, shares issued	1	1
Preferred stock, shares outstanding	1	1
Preferred Stock, Liquidation Preference, Value	$ 1	$ 1

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021	Jun. 30, 2020
Revenue
Total revenue	$ 7,824,784	$ 20,684,974	$ 12,573,276
Cost of revenue	3,141,041	8,119,487	6,209,724
Gross profit	4,683,743	12,565,487	6,363,552
Total Operating expenses:
Product development	3,166,088	6,271,966	3,206,310
Sales and marketing	3,928,028	9,108,173	7,792,480
General and administrative	4,435,067	10,422,207	11,320,715
Depreciation and amortization	2,007,237	5,735,150	1,315,898
Impairment of long-lived assets	6,887,000	14,383,310
Total operating expenses	20,423,420	45,920,806	23,635,403
Loss from operations	(15,739,677)	(33,355,319)	(17,271,851)
Other (expense) income:
Interest (expense) income, net	(193,084)	(1,531,497)	156,678
Change in fair value of convertible notes	(961,273)	(1,365,904)	766,000
Change in fair value of derivative liability	(746,852)	(248,198)	(1,962,034)
Gain on forgiveness of PPP Loan		2,234,730
Other (expense) income	(59,273)	186,420	(254)
Total other (expense) income	(466,778)	(228,053)	2,884,458
Net loss before income taxes and equity in losses of investee	(16,206,455)	(33,583,372)	(14,387,393)
Income tax (expense) benefit	(200)	2,262,225	(30,985)
Equity in losses of investee	(12,641)	(7,564)	(3,692)
Net Loss	(16,219,296)	(31,328,711)	(14,422,070)
Net loss attributable to noncontrolling interest in consolidated subsidiary	8,815		849,759
Net loss attributable to Akerna shareholders	$ (16,210,481)	$ (31,328,711)	$ (13,572,311)
Basic and diluted weighted average common shares outstanding	16,056,030	25,641,950	11,860,212
Basic and diluted net loss per common share	$ (1.01)	$ (1.22)	$ (1.14)
Software
Revenue
Total revenue	$ 6,766,985	$ 18,998,409	$ 9,976,580
Consulting
Revenue
Total revenue	916,099	1,510,413	2,379,947
Other
Revenue
Total revenue	$ 141,700	$ 176,152	$ 216,749

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021	Jun. 30, 2020
Statement of Comprehensive Income [Abstract]
Net loss	$ (16,219,296)	$ (31,328,711)	$ (14,422,070)
Other comprehensive (loss) income:
Foreign currency translation	(21,497)	53,020
Unrealized (loss) gain on convertible notes	(133,000)	100,000	63,000
Comprehensive loss	(16,373,793)	(31,175,691)	(14,359,070)
Comprehensive loss attributable to the noncontrolling interest	8,815		849,759
Comprehensive loss attributable to Akerna shareholders	$ (16,364,978)	$ (31,175,691)	$ (13,509,311)

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Total	Special Voting Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total Stockholder's Equity	Noncontrolling Interest in Consolidated Subsidiary
Balance at Jun. 30, 2019	$ 18,717,734		$ 1,059	$ 46,299,233		$ (27,582,558)	$ 18,717,734
Balance, shares at Jun. 30, 2019			10,589,746
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon warrant exercise	4,247,065		$ 37	4,247,028			4,247,065
Common stock issued upon warrant exercise, shares			369,311
Non-controlling interest in acquired subsidiary	5,554,011							5,554,011
Stock-based compensation amortization	1,253,234			1,253,234			1,253,234
Forfeitures of restricted shares			$ (5)	5
Forfeitures of restricted shares, shares			(54,901)
Change in fair value of Convertible Notes	63,000				63,000		63,000
Special voting preferred stock issued in business combination
Conversion of exchangable shares to common, shares
Settlement of convertible debt, shares
Common stock issued in business combinations	20,081,466		$ 230	20,081,236			20,081,466
Common stock issued in business combinations, shares			2,299,650
Warrant Adjustment	21,738			21,738			21,738
Net loss	(14,422,070)					(13,572,311)	(13,572,311)	(849,759)
Balance at Jun. 30, 2020	35,516,178		$ 1,321	71,902,474	63,000	(41,154,869)	30,811,926	4,704,252
Balance, shares at Jun. 30, 2020			13,203,806
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation amortization	1,298,540			1,298,540			1,298,540
Foreign currency translation adjustments	(21,497)				(21,497)		(21,497)
Special voting preferred stock issued in business combination	25,203,490	$ 25,203,490					25,203,490
Special voting preferred stock issued in business combination, shares		3,294,574
Issuance of common stock	11,032,380		$ 500	11,031,880			11,032,380
Issuance of common stock, shares			5,000,000
Conversion of exchangable shares to common		$ (4,798,271)	$ 63	4,798,208
Conversion of exchangable shares to common, shares		(627,225)	627,225
Acquisition of noncontrolling interests			$ 80	4,695,357			4,695,437	(4,695,437)
Balance as of July 1, 2020	35,702,003		1,321	71,902,474	63,000	(40,969,044)	30,997,751	4,704,252
Adoption of ASC 606 Adjustment	185,825					185,825	185,825
Balance as of July 1, 2020, shares			13,203,806
Acquisition of noncontrolling interest, shares			800,000
Settlement of convertible debt	360,000		$ 11	359,989			360,000
Settlement of convertible debt, shares			112,867
Restricted stock unit vesting			$ 15	(15)
Restricted stock unit vesting, shares			157,350
Unrealized loss (gains) on Convertible Notes	(133,000)				(133,000)		(133,000)
Net loss	(16,219,296)					(16,210,481)	(16,210,481)	(8,815)
Balance at Dec. 31, 2020	57,222,620	$ 20,405,219	$ 1,990	94,086,433	(91,497)	(57,179,525)	57,222,620
Balance, shares at Dec. 31, 2020		2,667,349	19,901,248
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation amortization	2,070,358			2,070,358			2,070,358
Forfeitures of restricted shares
Forfeitures of restricted shares, shares			(1,336)
Foreign currency translation adjustments	53,020				53,020		53,020
Special voting preferred stock issued in business combination
Issuance of common stock	$ 1,900,000
Issuance of common stock, shares	556,388
Conversion of exchangable shares to common		$ (18,039,181)	$ 237	18,038,944
Conversion of exchangable shares to common, shares		(2,358,063)	2,358,063
Settlement of convertible debt	11,610,586		$ 309	11,610,277			11,610,586
Settlement of convertible debt, shares			3,094,129
Restricted stock unit vesting			$ 42	(42)
Restricted stock unit vesting, shares			427,711
Unrealized loss (gains) on Convertible Notes	100,000				100,000		100,000
Settlement of liabilities with shares	430,025		$ 10	430,015			430,025
Settlement of liabilities with shares, shares			101,705
Shares issued in connection with Asset Purchase	300,000		$ 8	299,992			300,000
Shares issued in connection with Asset Purchase, shares			83,333
Shares issued in connection with 365 Cannabis Acquisition	11,996,061		$ 357	11,995,704			11,996,061
Shares issued in connection with 365 Cannabis Acquisition shares			3,571,429
Shares issued in connection with the ATM program	1,828,119		$ 56	1,828,063			1,828,119
Shares issued in connection with Viridian Acquisition	6,188,000		$ 103	6,187,897			6,188,000
Shares issued in connection with viridian acquisition, Shares			1,031,000
Shares withheld for withholding taxes	520,395		$ 12	520,383			520,395
Shares withheld for withholding taxes, shares			(121,786)
Net loss	(31,328,711)					(31,328,711)	(31,328,711)
Balance at Dec. 31, 2021	$ 59,949,683	$ 2,366,038	$ 3,100	$ 146,027,258	$ 61,523	$ 88,508,236	$ 59,949,683
Balance, shares at Dec. 31, 2021		309,286	31,001,884
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued in connection with the ATM program, share			556,388

Consolidated Statements of Cash

Consolidated Statements of Cash Flows	6 Months Ended	12 Months Ended
	Dec. 31, 2020USD ($)	Dec. 31, 2021USD ($)	Jun. 30, 2020USD ($)
Cash flows from operating activities
Net loss	$ (16,219,296)	$ (31,328,711)	$ (14,422,070)
Adjustment to reconcile net loss to net cash used in operating activities
Equity in losses of investment	12,643	7,564	3,692
Bad debt expense	72,832	556,890	1,094,507
Stock-based compensation expense	1,197,589	2,070,359	1,166,130
Loss on write off of fixed assets		1,045,179
Gain on forgiveness of PPP loan		(2,234,730)
Depreciation and amortization	2,007,237	5,735,150	1,315,898
Amortization of deferred contract costs	228,766	492,683
Non-cash interest expense	32,727	1,009,331
Foreign currency loss		(3,312)
Impairment of long-lived assets	6,887,000	14,383,310
Gain on debt extinguishment		(186,177)
Loss on sale of fixed asset	84,835
Debt issuance costs			1,177,390
Change in fair value of convertible notes	961,273	1,365,904	(766,000)
Change in fair value of derivative liability	(746,852)	(248,198)	(1,962,034)
Change in fair value of contingent consideration	(993,000)		(998,000)
Changes in operating assets and liabilities:
Accounts receivable	1,008,775	849,785	(1,621,262)
Prepaid expenses and other current assets	(689,729)	(8,988)	(592,807)
Other assets	41,925		(58,925)
Accounts payable, accrued expenses and other current liabilities	(2,498,375)	1,610,470	1,602,751
Deferred tax liabilities		(2,274,295)
Deferred revenue	(94,088)	(1,010,118)	(286,922)
Net cash used in operating activities	(8,705,738)	(8,167,904)	(14,347,652)
Cash flows from investing activities
Developed software additions	(1,847,710)	(5,427,230)	(3,102,728)
Furniture, fixtures, and equipment additions	(12,203)	(39,263)	(156,636)
Cash paid for business combinations, net of cash acquired	(5,279,134)	(5,018,592)	(88,720)
Investment in equity method investee			(250,000)
Net cash used by investing activities	(7,139,047)	(10,485,085)	(3,598,084)
Cash flows from financing activities
Value of shares withheld related to tax withholdings		520,395
Proceeds from stock offering, net		1,828,119
Proceeds from the issuance of long term debt		18,000,000	17,164,600
Payments of principal amounts of debt
Payments on debt	(1,500,000)	(4,571,472)
Cash paid for debt issuance costs			(1,177,390)
Proceeds from the exercise of warrants			4,247,065
Proceeds from the issuance of common stock	12,000,000
Offering costs from the issuance of common stock	(967,620)
Net cash provided by financing activities	9,532,380	14,736,252	20,234,275
Effect of exchange rate changes on cash and restricted cash	(2,783)	18,623
Net (decrease) increase in cash and restricted cash	(6,315,188)	(3,898,114)	2,288,539
Cash and restricted cash - beginning of period	24,655,828	18,340,640	22,367,289
Cash and restricted cash - end of period	18,340,640	14,442,526	24,655,828
Cash paid for taxes		10,570
Cash paid for interest	150,000	507,941
Supplemental disclosure of non-cash investing and financing activity:
Adjustments due to the adoption of ASC 606	185,826
Vesting of restricted stock units	15	42
Settlement of convertible notes in common stock	327,273	11,610,586
Stock-based compensation capitalized as software development	100,951	36,915	87,104
Acquisition of noncontrolling interest	4,695,437
Capitalized software included in accrued expenses	189,198	554,127
Conversion amount	4,798,271	18,038,944
Adjustment to Trellis purchase price allocation	14,300
Settlement of liabilities with common stock		430,015
Shares issued in connection with an asset purchase		8
Assets acquired and liabilities assumed in business combinations:
Cash	445,269	527,346
Accounts receivable	917,205	1,041,912	77,505
Prepaid expenses and other current assets	596,233	408,973	27,860
Fixed assets	1,326,996	93,365	2,410
Intangible assets	3,795,000	16,933,000	8,010,000
Goodwill	25,805,615	19,451,464	20,254,309
Accounts payable and accrued liabilities	805,114	1,174,961	1,441,062
Deferred tax liabilities		2,949,586
Deferred revenue	549,311	4,301,514	31,220
Contingent consideration	$ 604,000	$ 6,300,000	$ 1,387,000

Description of Business, Liquid

Description of Business, Liquidity, and Capital Resources	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business, Liquidity, and Capital Resources	Note 1 - Description of Bu sines Resources Description of Business Akerna Corp., herein referred to as we, us, our or Akerna, through our wholly-owned subsidiaries MJ Freeway, LLC, or MJF, Trellis Solutions, Inc., or Trellis, Ample Organics, Inc, or Ample, o ur commercial software platform, MJ Platform®, Trellis®, Ample, Viridian and 365 Cannabis to state-licensed businesses, and our regulatory software platform, Leaf Data Systems®, to state government regulatory agencies. Through Solo, we provide an innovative, next-generation solution for state and national governments to securely track product and waste throughout the supply chain with solo*TAG ™ . ™ We consult with clients on a wide range of areas to help them successfully maintain compliance with state laws and regulations. We provide project-focused consulting services to clients who are initiating or expanding their cannabis business operations or are interested in data consulting engagements with respect to the legal cannabis industry. Our advisory engagements include service offerings focused on compliance requirement assessments, readiness and best practices, compliance monitoring systems, application processes, inspection readiness, and business plan and compliance reviews. We typically provide our consulting services to clients in emerging markets that are seeking consultation on newly introduced licensing regimes and assistance with the regulatory compliant build-out of operations. Going Concern and Management's Liquidity Plans In accordance with the Financial Accounting Standards Board’s (“FASB”) standard on going concern, Accounting Standard Update, or ASU No. 2014-15, The Company assesses going concern uncertainty in its consolidated financial statements to determine if it has sufficient cash, cash equivalents and working capital on hand, including marketable equity securities, and any available borrowings on loans, to operate for a period of at least one year from the date the consolidated financial statements are issued, which is referred to as the “look-forward period” as defined by ASU No. 2014-15. As part of this assessment, based on conditions that are known and reasonably knowable to The Company, it will consider various scenarios, forecasts, projections, estimates and will make certain key assumptions, including the timing and nature of projected cash expenditures or programs, and its ability to delay or curtail expenditures or programs, if necessary, among other factors. Based on this assessment, as necessary or applicable, The Company makes certain assumptions around implementing curtailments or delays in the nature and timing of programs and expenditures to the extent The Company deems probable those implementations can be achieved and it has the proper authority to execute them within the look-forward period in accordance with ASU No. 2014-15. The accompanying consolidated financial statements have been prepared on the basis that we will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. However, since During the year ended $15.7 million $17.3 million, respectively, and $8.2 million, $ t of $10.9 13.9 million in These factors raise substantial doubt, as defined by generally accepted accounting principles in the United States of America ("GAAP"), about the ability of the company to continue to operate as a going concern for the On July 23, 2021, we entered into an Equity Distribution Agreement with Oppenheimer & Co. On October 5, 2021, we entered into a securities purchase agreement with the The Senior Convertible Notes mature on October 5, 2024 and are to be repaid in monthly installments beginning on January 1, 2022. The Senior Convertible Notes can be repaid in common shares or cash. Management’s plan for the Company to continue as a going concern includes raising additional capital from our ATM program, subject to certain effects on the Senior Convertible Notes should we utilize the program, including resetting the conversion price of the Senior Convertible Notes should we raise more than $ 5 million The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. We will require additional financing in the second quarter of 2022 to meet our ongoing operational working capital requirements and continue to meet the financial covenants of the Senior Convertible Notes. As noted above, we plan to meet those requirements in part through the use of our ATM Facility, but there are no guarantees that the ATM Facility will permit us to raise sufficient cash to meet our ongoing requirements. These factors raise substantial doubt about the Company’s ability to continue as a going concern for one year from the issuance of the consolidated financial statements. If we are unable to raise sufficient capital we may have to reduce operations which could significantly affect our results of operations. If we fail to meet the financial covenants of the Senior Convertible Notes and cannot obtain a waiver from such provisions or otherwise come to an agreement with the holders of our debt, such holders may declare a default on the debt which could subject our assets to seizure and sale, negatively impacting our business. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary if the Company is unable to continue as a going concern.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with GAAP. In September 2020, the Company changed its fiscal year from June 30 to December 31. As a result, this annual report on Form 10-K includes the consolidated financial statements as of December 31, 2021 and December 31, 2020 and for (i) the calendar year ended December 31, 2021, (ii) the transitional six months ended December 31, 2020; and (iii) the fiscal year ended June 30, 2020. Principles of Consolidation Our accompanying consolidated financial statements include the accounts of Akerna, our wholly-owned subsidiaries, and those entities in which we otherwise have a controlling financial interest. All significant intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the consolidated financial statements and accompanying notes thereto. Our most significant estimates and assumptions are related to the valuation of acquisition-related assets and liabilities, capitalization of internal costs associated with software development, fair value measurements, impairment assessments, loss contingencies, valuation allowance associated with deferred tax assets, stock based compensation expenses, and useful lives of long-lived intangible assets. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results could differ from those estimates. Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation. Foreign Currency The functional currency of the Company's non-U.S. operations is the local currency. Monetary assets and liabilities denominated in foreign currencies are translated into U.S. dollars at exchange rates prevailing at the balance sheet dates. Non-monetary assets and liabilities are translated at the historical rates in effect when the assets were acquired or obligations incurred. Revenue and expenses are translated into U.S. dollars using the average rates of exchange prevailing during the period. Translation gains or losses are included as a component of accumulated other comprehensive loss in stockholders' equity. Gains and l Cash and Cash Equivalents We consider liquid instruments purchased with an original maturity of three months or less to be cash equivalents. There were no cash equivalents as of December 31, 2021, and 2020. We continually monitor our positions with, and the credit quality of, the financial institutions with which we invest. As of the balance sheet date, and periodically throughout the year, we have maintained balances in various operating accounts in excess of federally insured limits. Restricted Cash Restricted cash consists of funds that are contractually or legally restricted as to usage or withdrawal and is presented separately from cash and cash equivalents on our consolidated balance sheets. Our restricted cash serves as collateral for a letter of credit. Accounts Receivable, Net We maintain an allowance for doubtful accounts equal to the estimated uncollectible amounts based on our historical collection experience and review of the current status of trade accounts receivable. Receivables are written-off and charged against the recorded allowance when we have exhausted collection efforts without success. The allowance for doubtful accounts wa s $0.3 million as of December 31, 2021, and 2020, respectively The allowance for doubtful accounts consists of the following activity: Year Ended December 31, Six Months Ended December 31, 2021 2020 Allowance for doubtful accounts, balance at beginning of period $ 153,500 $ 208,422 B ad debt expense 556,890 72,832 Write-off uncollectable accounts (393,306) ( 127,754 ) Allowance for doubtful accounts, balance at end of period $ 317,084 $ 153,500 Concentrations of Credit Risk We grant credit in the normal course of business to customers in the United States. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk. During the year ended December 31, 2021, the six months ended December 31, 2020 and the year ended June 30, 2 020, one government client accounted for 11%, % and 25% of total revenues, respectively. As of December 31, 2020, two government clients accounted f or a total of 36% of net accounts receivable. Property and Equipment Property and equipment are recorded at cost. Expenditures for major additions and improvements are capitalized. Depreciation and amortization is provided over the estimated useful lives of the related assets using the straight-line method. The estimated useful lives for significant property and equipment categories are generally as follows: Furniture and computer equipment 3 to 7 years Leasehold improvements Lesser of remaining lease term or useful life Repairs and maintenance costs are expensed as incurred. Warrant Liabilities Company’s - . As a result, these warrants are precluded from equity classification and are recorded as derivative liabilities. At the end of each reporting period, changes in fair value during the period are recognized within the condensed consolidated statements of operations and comprehensive loss. We will continue to adjust the warrant liability for changes in the fair value until the earlier of a) the exercise or expiration of the warrants or b) the redemption of the warrants, at which time the warrants will be reclassified to additional paid-in capital. Investment We Intangible Assets Acquired through Business Combinations Intangible assets are amortized over their estimated useful lives. We evaluate the estimated remaining useful life of our intangible assets when events or changes in circumstances indicate an adjustment to the remaining amortization may be needed. We similarly evaluate the recoverability of these assets upon events or changes in circumstances indicate a potential impairment. Recoverability of these assets is measured by comparing the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate. If the undiscounted cash flows used in the test for recoverability are less than the carrying amount of these assets, the carrying amount of such assets is reduced to fair value. We recorded an impairment of $ 2.7 million Goodwill Impairment Assessment Goodwill represents the excess purchase consideration of an acquired business over the fair value of the net tangible and identifiable intangible assets. Goodwill is evaluated for impairment annually on October 31, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate or a significant decrease in expected cash flows. An impairment loss is recognized to the extent that the carrying amount exceeds the reporting unit’s fair value, not to exceed the carrying amount of goodwill. The Company has the option to first assess qualitative factors to determine whether events or circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying amount and determine whether further action is needed. If, after assessing the totality of events or circumstances, the Company determines it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the quantitative impairment test is unnecessary. Due to a continued decline in market conditions and declines in the operating results of our non-enterprise reporting unit, we recognized an impairment to goodwil l of $ million Software Development Costs Costs incurred during the application development stage of a newly developed application and costs we incur to enhance our existing platforms that meet certain criteria are subject to capitalization and subsequent amortization. Capitalized software development costs were approximatel y $5.9 million d urin g the year ended December 31, 2021, $ 2.1 during the ch as payroll Fair Value of Financial Instruments GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, we are required to classify certain assets and liabilities based on the fair value hierarchy, which groups fair value-measured assets and liabilities based upon the following levels of inputs: ● Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; ● Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; ● Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity). The fair value of financial instruments is the amount at which the instrument could be exchanged in a current transaction between willing parties. The carrying values of financial instruments such as accounts receivable, accounts payable and accrued liabilities approximate fair value based on their short maturities. Please refer to Note 13 - Fair Value Measurements for additional Fair Value Option The fair value option provides an election that allows a company to irrevocably elect to record certain financial assets and liabilities at fair value on an instrument-by-instrument basis at initial recognition. We have elected to apply the fair value option to certain convertible notes due to the complexity of the various conversion and settlement options available to both the Note Holders and Akerna. The convertible notes accounted for under the fair value option election are each a debt host financial instrument containing embedded features that would otherwise be required to be bifurcated from the debt-host and recognized as separate derivative liabilities subject to initial and subsequent periodic estimated fair value measurements in accordance with GAAP. Notwithstanding, when the fair value option election is applied to financial liabilities, bifurcation of an embedded derivative is not required, and the financial liability is initially measured at its issue-date estimated fair value and then subsequently remeasured at estimated fair value on a recurring basis as of each reporting period date. The portion of the change in fair value attributed to a change in the instrument-specific credit risk is recognized as a component of other comprehensive income and the remaining amount of the fair value adjustment is recognized as other income (expense) in our consolidated statement of operations. The estimated fair value adjustment is presented in a respective single line item within other income (expense) in the accompanying consolidated statement of operations because the change in fair value of the convertible notes was not attributable to instrument-specific credit risk. Revenue Recognition See Note 3 for further discussion of our revenue recognition policies. Cost of Revenue Cost of revenue consists primarily of costs related to providing subscription and other services to our customers, including employee compensation and related expenses for data center operations, customer support and professional services personnel, payments to outside technology service providers, security services, and other tools. Product Development Product development expenses consist primarily of employee-related costs for the design and development of the Company's platform, contractor costs to supplement staff levels, third-party web services, consulting services, and allocated overhead. Product development expenses, other than software development costs qualifying for capitalization, are expensed as incurred. Sales and Marketing Expenses Sales and marketing expenses con General and Administrative General and administrative expenses consist primarily of personnel and related costs for our executive, finance, legal, human resources, and administrative personnel, including salaries, b nefits, bonuses, and stock-based compensation; legal, accounting, and other professional service fees; other corporate expenses; information technology costs; restructuring charges such as lease termination costs; and facility costs. Legal and Other Contingencies From time to time, the Company may be a party to litigation and subject to claims incident to the ordinary course of business, including intellectual property claims, labor and employment claims, breach of contract claims and other asserted and unasserted claims. The Company investigates these claims as they arise and accrues estimates for resolution of legal and other contingencies when losses are probable and estimable. Stock-Based Compensation We measured stock-based compensation based on the fair value of the share-based awards on the date of grant and recognize the related costs on a straight-line basis over the requisite service period, which is generally the vesting period. Income Taxes Income taxes are accounted for using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of other assets and liabilities. We provide for income taxes at the current and future enacted tax rates and laws applicable in each taxing jurisdiction. We use a two-step approach for recognizing and measuring tax benefits taken or expected to be taken in a tax return and disclosures regarding uncertainties in income tax positions. We recognize interest and penalties related to income tax matters in selling, general and administrative expenses in the consolidated statement of operations. We recognize deferred tax assets to the extent that its assets are more likely than not to be realized. In making such a determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and results of recent operations. If we determine that we would be able to realize our deferred tax assets in the future in excess of its net recorded amount, we will make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes. As of December 31, 2021, management has applied a valuation allowance to deferred tax assets when it is determined that the benefit from the deferred tax asset will not be able to be utilized in a future period. Segments Our chief operating decision maker reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance and information for different revenue streams is not evaluated separately. As such, the Company has one operating segment, and the decision-making group is the senior executive management team. In the following table, we disclose our long-lived assets by geographical location 2021 2020 Long-lived assets: United States $ 32,356 $ 9,994 Canada 5,229 5,074 Total $ 37,585 $ 15,068 Subsequent Events The Recently Issued Accounting Pronouncements ASU 2016-02 The Financial Accounting Standards Board, or the FASB, has issued new guidance related to the accounting for leases. The new standard establishes a right-of-use model that requires a lessee to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of operations. We ASU 2016-13 The FASB has issued guidance to introduce a new model for recognizing credit losses on financial instruments based on estimated current expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based on historical information, current conditions, and reasonable and supportable forecasts. Following our change in fiscal year-end effective December 31, 2020, the new guidance is effective for us begi ASU 2018-15 The FASB has issued guidance to help entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement (hosting arrangement) by providing guidance for determining when the arrangement includes a software license. ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The guidance (i) provides criteria for determining which implementation costs to capitalize as an asset related to the service contract and which costs to expense, (ii) requires an entity (customer) to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement and (iii) clarifies the presentation requirements for reporting such costs in the entity’s consolidated financial statements. We have adopted this standard effective December 15, 2021, and there is currently no impact to our consolidated financial statements as a result of this guidance. ASU 2019-12 In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which aims to reduce complexity in accounting standards by improving certain areas of U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) without compromising information provided to users of financial statements. ASU 2019-12 is effective for public entities for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. For all other entities, the standard is effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company has adopted ASU 2019-12 effective December 15, 2021 and the adoption of this guidance did not have a significant effect on our consolidated financial statements. ASU 2020-01 The FASB has issued guidance clarifying the interactions between various standards governing investments in equity securities. The new guidance addresses accounting for the transition into and out of the equity method and measurement of certain purchased options and forward contracts to acquire investments. The standard is effective for us for annual and interim periods beginning on January 1, 2022, with early adoption permitted. Adoption of the standard requires changes to be made prospectively. We do not anticipate a significant impact to our consolidated financial statements as a result of this new guidance. ASU 2020-06 In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options and Derivative and Hedging - Contracts in Entity’s Own Equity, which simplifies the accounting for convertible instruments. This guidance eliminates certain models that require separate accounting for embedded conversion features, in certain cases. Additionally, among other changes, the guidance eliminates certain of the conditions for equity classification for contracts in an entity’s own equity. The guidance also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. This guidance is required to be adopted by us in the first quarter of 2023 and must be applied using either a modified or full retrospective approach. We are currently evaluating the impact this guidance will have on our consolidated financial statements. ASU 2021-04 On May 3, 2021, FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Enti We are currently evaluating the impact this guidance will have on our consolidated financial statements. ASU 2021-08 In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which amends the accounting related to contract assets and liabili We are currently evaluating the impact this guidance will have on our consolidated financial statements.

Revenue

Revenue	12 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Revenue	Note 3 - Revenue Financial Statement Impact of Adopting ASC 606, "Revenue from Contracts with Customers" On July 1, 2020, we adopted ASC 606 using the modified retrospective transition method and applied this method to all contracts that were not complete as of the date of adoption. The reported results as of December 31, 2021 and December 31, 2020, and for the year ended December 31, 2021 and the six months ended December 31, 2020 in the accompanying consolidated financial statements are presented under ASC 606, while the year ended June 30, 2020 has not been adjusted and is reported in accordance with historical accounting guidance in effect for that period. The most significant impacts of this standard relate to the timing of revenue recognition of fixed fees under our contracts, as well as the accounting for costs to obtain contracts. Under ASC 606, revenue recognition for subscription and implementation fees begins on the launch date and is recognized over time through the term of the contract. We then recognized the remaining balance of the fixed fees ratably over the remaining term of the contract. Additionally, under ASC 606, we now defer recognition of expense for sales commissions ("contract costs"). These contract costs are amortized to expense over the expected period of benefit. Before the adoption of ASC 606, we expensed these contract costs as incurred. The adoption of ASC 606 $ 0.2 million 0.2 Revenue Recognition Policies for the year ended December 31, 2021 and the six months ended December 31, 2020 In accordance with ASC Software Revenue. 365 30 We typically invoice customers at the beginning of the term, in multi-year, annual, quarterly, or monthly installments. When a collection of fees occurs in advance of service delivery, revenue recognition is deferred until such services commence. Revenue for implementation fees is recognized ratably over the expected term of the contract, including expected renewals. We include service level commitments to customers warranting certain levels of uptime reliability and performance and permitting those customers to receive credits if those levels are not met. In addition, customer contracts often include: specific obligations that require us to maintain the availability of the customer’s data through the service and that customer content is secured against unauthorized access or loss, and indemnity provisions whereby we indemnify customers from third-party claims asserted against them that result from our failure to maintain the availability of their content or securing the same from unauthorized access or loss. To date, we have not incurred any material costs as a result of such commitments. Any such credits or payments made to customers under these arrangements are recorded as a reduction of revenue. Consulting Revenue. consists of contracts with fixed terms and fee structures based upon the volume and activity or fixed-price contracts for consulting and strategic services. Consulting services revenue When these services are not combined with subscription revenues as a single unit of account, these revenues are recognized as services are rendered and accepted by the customer. Other Revenue. Our other revenue is derived primarily from point-of-sale hardware and other non-recurring revenue. We sell solo*TAG ™ s and solo*CODE ™ s to customers by the roll of printed labels or as a digital code that allows customers to print directly their packing. When customers active a solo*TAG ™ or solo*CODE ™ , we receive an activation fee, which is recognized upon activation by the customer. From time to time, we may purchase equipment for resale to customers. Such equipment is generally drop-shipped to our customers. We recognize revenue as these products are delivered. Cost of Revenue. Cost of revenue consists primarily of costs related to providing subscription and other services to our customers, including employee compensation and related expenses for data center operations, customer support and professional services personnel, payments to outside technology service providers, security services, and other tools. Unbilled Receivables. Unbilled receivables are booked when services are delivered to our customers but not yet invoiced. Once invoiced, the unbilled receivables are reclassified to accounts receivable. Revenue Recognition Policies for the year ended June 30, 2020 We derive our revenues primarily from the following sources: software revenues, which are primarily comprised of subscription fees from government and commercial customers accessing our enterprise cloud computing services and from customers paying for additional support beyond the standard support that is included in the basic subscription fees; and consulting services provided to operators interested in integrating our platform into their respective operations, such services include: assessing compliance requirements, monitoring systems and readiness; assisting with the application process; and evaluating the operator’s inspection readiness and business plan. We commence revenue recognition when there is persuasive evidence of an arrangement, the service has been or is being provided to the customer, the collection of the fees is reasonably assured, and the amount of fees to be paid by the customer is fixed or determinable. Deferred Revenue Deferred revenue consists of payments received in advance of revenue recognition from subscription services. The deferred revenue balance is influenced by several factors, including seasonality, the compounding effects of renewals, contract duration, and invoice frequency. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as deferred revenue, which is a current liability on the accompanying consolidated balance sheets. Disaggregation of Revenue The Company derives the majority of its revenue from subscription fees paid for access to and usage of its SaaS solutions for a specified period of time, typically one to three years. In addition to subscription fees, contracts with customers may include implementation fees for launch assistance and training. Fixed subscription and implementation fees are billed in advance of the subscription term and are due in accordance with contract terms, which generally provide for payment within 30 days. The Company's contracts typically have a one to three year term. The Company's contractual arrangements include performance, termination and cancellation provisions, but do not provide for refunds. Customers do not have the contractual right to take possession of the Company's software at any time. Sales

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2021
Business Combinations [Abstract]
Acquisitions	Note 4 – Acquisitions 2021 Ac quisit Viridian Sciences On April 1, 2021, we completed the acquisition of Viridian, a cannabis business management software provider that is built on SAP Business One 1.0 ap proximately 6.0 1.0 Preliminary Fair Value Shares issued $ 6,186 Contingent co nsidera 2 Total preliminary fair value of consideration transferred $ 6,188 The following table summarizes the preliminary fair values of assets acquired and liabilities assumed as of the date of acquisition (in thousands): Preliminary Fair Value Accounts receivable 556 Prepaid expenses and other current assets 148 Capitalized software 423 Acquired technology 470 Customer relationships 820 Acquired trade name 20 Goodwill 5,408 Accounts payable and accrued expenses (350 ) Deferred tax liabilities (307 ) Deferred revenue (1,000 ) Net assets acquired $ 6,188 The excess of purchase consideration over the fair value of assets acquired and liabilities assumed was recorded as goodwill, which is primarily attributed to the assembled workforce and expanded market opportunities, for which there is no basis for U.S. income tax purposes. The fair values assigned to identifiable assets acquired and liabilities assumed are based on management’s estimates and assumptions. We expect to finalize the valuation as soon as practicable, but no later than one The amounts of Viridian's revenue and net income included in our consolidated statement of operations from the acquisition date of April 1, 2021, to December 31, 2021 were $ 2.4 0.3 365 On October 1, 2021, we acquired all the issued and outstanding shares of 365 3.6 These rights are accounted for as contingent consideration and are currently recorded at preliminary fair value which will be updated upon finalization of purchase accounting. Preliminary Fair Value Shares issued $ 12,000 Cash 5,542 Contingent co nsidera 6,300 Total preliminary fair value of consideration transferred $ 23,842 The following table summarizes the preliminary fair values of assets acquired and liabilities assumed as of the date of acquisition (in thousands Preliminary Fair Value Cash 527 Accounts receivable 486 Prepaid expenses and other current asset 261 Fixed Assets 93 Non-compete agreement 80 Acquired technology 1,040 Customer relationships 13,810 Acquired trade name 270 Goodwill 14,043 Accounts payable and accrued expenses (826 ) Deferred tax liabilities (2,642 ) Deferred revenue (3,300 ) Net assets acquired $ 23,842 The excess of purchase consideration over the fair value of assets acquired and liabilities assumed was recorded as goodwill, which is primarily attributed to the assembled workforce and expanded market opportunities, for which there is no basis for U.S. income tax purposes. The fair values assigned to identifiable assets acquired and liabilities assumed are based on management’s estimates and assumptions. We expect to finalize the valuation as soon as practicable, but no later than one The amounts of 365 Cannabis' million and $0.4 million 2020 A cquisitions Trellis Solutions, Inc. On April 8, 2020, we acquired Trellis, a cannabis cultivation management and compliance software company in an all-stock transaction Our estimated acquisition date fair value of the consideration transferred for Trellis was as follows (in thousands): Common shares issued $ 2,531 Cont ingent consid 998 Total estimated fair value of consideration $ 3,529 We incurred $ of transaction costs directly related to the acquisition that is reflected in general and administrative expenses in our consolidated statement of operations during the year ended June 30, 2020. We issued 349,650 shares of our common stock valued at $7.24 We have also agreed to pay additional consideration calculated as annualized revenue derived from previously identified customers for the month of September 2020 multiplied by five. The contingent consideration is payable in shares based on the 20-day volume-weighted average price, or VWAP. At June 30, 2020, we estimated the fair value of the contingent consideration to be $0 and recorded a gain of $1.0 million on the change in the fair value of contingent consideration included in general and administrative expenses in the consolidated statement of operations during the year ended June 30, 2020. The following table summarizes our estimated fair values of assets acquired and liabilities assumed as of the date of acquisition (in thousands): Cash $ 21 Accounts receivable, net 91 Other assets 6 Acquired technology 210 Acquired trade name 80 Customer relationships 220 Goodwill 3,216 Accounts payable and accrued expenses (284 ) Deferred revenue (31 ) Net assets acquired $ 3,529 The excess of purchase consideration over the fair value of net tangible and intangible assets acquired was recorded as goodwill, which is primarily attributed to the assembled workforce and expanded market opportunities, for which there is no basis for U.S. income tax purposes. During the six months ended December 31, 2020, we recorded net adjustments to assets and liabilities acquired of $14.3 thousand. thousand thousand, solo sciences, inc. On January 15, 2020, we closed on a stock purchase agreement with substantially all of the shareholders of Solo pursuant to which we acquired all right, title, and interest in 80.4 % A s The estimated acquisition date fair value of the consideration $ mi . During the yea r ended June 30, 2020, w e completed the preliminary valuation of the contingent consideration and recorded a measurement perio d adjustment to reflect this liability on our balance sheet. The estimated fair value of consideration recorded consisted of the following (in thousands): Common shares issued $ 17,550 Contingent considerat 389 Total estimated fair value of consideration $ 17,939 We incurred $0.3 million of transaction costs directly related to the acquisition, which is reflected in general and administrative expenses in our consolidated statement of operations during the year ended June 30, 2020. We exchanged 1,950,000 shares of our common stock, valued at $9.00 per share, the closing price of a share of our common stock on the date of acquisition. In addition to the stock consideration, we agreed to pay contingent consideration in the form of fees payable to the legacy Solo shareholders equal to the lesser of (i) $0.01 per solo*TAG™ and solo*CODE™ sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAG™ and solo*CODE™, which is December 1, 2029. This fee represents contingent consideration and was recorded at fair value as of the date of acquisition. Contingent consideration is adjusted to fair value each period with changes in fair value being recognized in earnings at each reporting period. We also acquired an option to acquire the interests in Solo during the 12 months following the close for either cash or shares. Beginning with the expiration of our option, the interests in Solo have a 3-month option to acquire between 40% and 55% of Solo back from us for cash. On July 31, 2020, we entered into an amendment to the stock purchase agreement to exercise our option to acquire the noncontrolling interests in Solo, for 800,000 shares of our common stock, this transaction will be recorded as an equity transaction, with no effect to the value of the assets acquired or liabilities assumed. In connection with the amendment, the selling shareholders agreed to cancel the contingent consideration in the future and waived a right to any amount that would have been earned prior to the amendment. We recorded a gain on settlement of the contingent consideration liability during the six months ended December 31, 2020 in general and administrative expenses in our consolidated statement of operations. During the year ended June 30, 2020, we obtained additional information regarding the valuation of the assets acquired and liabilities assumed. We have recorded a measurement period adjustment to allocate the acquisition price to intangible assets, goodwill, accrued liabilities, and the fair value of noncontrolling interests. The following table summarizes the estimated fair values of assets acquired and liabilities assumed as of the date of acquisition (in thousands): Cash $ 101 Prepaid expenses and other assets 22 Furniture, fixtures, and equipment 2 Acquired technology 7,160 Acquired trade name 340 Goodwill 17,025 Accounts payable and accrued liabilities (1,158 ) Fair value of noncontrolling interests (5,553 ) Net assets acquired $ 17,939 The excess of purchase consideration over the fair value of net tangible and intangible assets acquired was recorded as goodwill, which is primarily attributed to expanded market opportunities, for which there is no basis for U.S. income tax purposes. thousand million , respectively. During the six months ended December 31, 2020, the Company recorded an impairment of $2.7 million related to Solo’s developed technology. See Note 6 – Goodwill and Intangible Assets, Net for further discussion of the intangible asset impairment. Ample Organics On July 7, 2020, we completed the acquisition of Ample Organics (“Ample”), Ample provides a seed-to-sale platform to clients in Canada, which offers tracking, reporting, and compliance tools to cannabis cultivators, processors, sellers, and clinics. We acquired 100% of the stock of Ample Organics for 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, $30.7 million was the aggregate value of the exchangeable shares. In addition to the stock consideration, we paid $5.5 million in cash, which was used to settle all of Ample's then outstanding debt. In addition to the stock and cash consideration, the agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition. Preliminary Exchangeable shares issued $ 25,203 Cash 5,724 Contingent consideration 604 Total estimated fair value of consideration transferred $ 31,531 We incurred $ million of total transaction costs directly related to the acquisition of Ample that is reflected in general and administrative expenses in our consolidated statements of operations , of which $1.1 million and $1.8 million was recognized and the year ended June 30, 2020, respectively The following table summarizes the estimated fair values of assets acquired and liabilities assumed as of the date of acquisition (in thousands): Preliminary Cash $ 445 Accounts receivable 917 Prepaid expenses and other current assets 595 Acquired technology 850 Customer relationships 2,660 Acquired trade name 285 Goodwill 25,806 Furniture, fixtures and equipment 1,327 Accounts payable and accrued expenses (805 ) Deferred revenue (549 ) Net assets acquired $ 31,531 The excess of purchase consideration over the preliminary fair value of assets acquired and liabilities assumed was recorded as goodwill, which is primarily attributed to the assembled workforce and expanded market opportunities, for which there is no basis for U.S. income tax purposes. During the six months ended December 31, 2020, the Company recorded an impairment to goodwill for $4.2 million related to Ample. See Note 6 – Goodwill and Intangible Assets, Net for further discussion of the goodwill impairment. The amounts of Ample’s revenue and net income included in our consolidated statement of operations from the acquisition date of July 7, 2020, to December 31, 2020 were $2.6 million and $0.1 million, respectively. Pro Forma Financial Information The following unaudited pro forma consolidated operating results give effect to the Viridian and 365 Cannabis acquisitions as if they had been completed as of January 1, 2020 (in thousands): Year Ended December 31, 2021 Revenue $ 28,847 Net loss $ (31,423 ) The following unaudited pro forma consolidated operating results give effect to t he Viridian and 365 Cannabis acquisitions, as if they had been completed as of January 1, 2020, and t Six Months Ended December 31, Year Ended June 30, 2020 2020 Revenue $ 14,026 $ 27,523 Net loss $ ( ) $ (20,250 ) The pro forma financial information for all periods presented above has been calculated after adjusting the results of Solo, Trellis, Ample, Viridian, and 365 Cannabis to reflect the business combination accounting effects resulting from this acquisition, including the amortization expense from acquired intangible assets as though the acquisition occurred as of the beginning of the periods indicated above. T he pro forma financial information is for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place at the beginning of the years indicated above. Special Voting Preferred Stock and Exchangeable Shares In connection with the Ample acquisition, we entered into agreements with our wholly-owned subsidiary and the Ample shareholder representative that resulted in the issuance of a single share of our special voting preferred stock, for the purpose of ensuring that each Exchangeable Share is substantially the economic and voting equivalent of a share of Akerna common stock, and, following the registration of the Akerna shares issuable upon exchange of the Exchangeable Shares under the Securities Act of , ensuring that each Exchangeable Share is exchangeable on a -for- basis for a share of Akerna common stock, subject to certain limitations. As a result of these agreements and the issuance of the special voting preferred stock, each holder of Exchangeable Shares effectively has the ability to cast votes along with holders of Akerna common stock. Additionally, these agreements grant exchange rights to the holders of exchangeable shares upon the event of our liquidation, dissolution or winding up. The special voting preferred stock has a par value of $ 0.0001 . The special voting preferred stock entitles the holder to an aggregate number of votes equal to the number of the exchangeable shares issued and outstanding from time to time and which we do not own. The holder of the special voting preferred stock and the holders of shares of Akerna common stock will both together as a single class on all matters submitted to a vote of our shareholders. At such time as the special voting preferred stock has not votes attached to it, the share shall be automatically cancelled. The exchangeable shares do not have a par value. On September 1, 2020, several Ample shareholders exchanged a total of exchangeable shares with a value of $ for the same number of shares of Akerna common stock.The exchange was accounted for as an equity transaction and we did not recognize a gain or loss on this transaction. As of December 31, 2021, there were a total of Exchangeable Shares issued and outstanding.

Balance Sheet Disclosures

Balance Sheet Disclosures	12 Months Ended
	Dec. 31, 2021
Balance Sheet Disclosures [Abstract]
Balance Sheet Disclosures	Note 5 - Balance Sheet Disclosures Prepaid expenses and other current assets consisted of the following As of December 31, 2021 2020 Software and technology $ 687,740 $ 480,651 Professional services, dues and subscriptions 546,126 826,195 Insurance 264,097 243,222 Deferred contract costs 260,899 227,718 Unbilled receivable 506,984 612,446 Other 117,918 Total prepaid expenses and other current assets $ 2,383,764 $ 2,458,727 Accounts payable, accrued expenses and other current liabilities consisted of the following: As of December 31 2021 2020 Accounts payable $ 1,943,457 $ 513,610 Professional fees 319,590 233,667 Sales taxes 360,361 216,367 Compensation 1,123,467 311,379 Contractors 1,288,730 538,618 Settlements and legal 681,045 831,232 Other 346,870 543,703 Total accounts payable, accrued expenses and other current liabilities $ 6,063,520 $ 3,188,576

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	Note 6 - Goodwill and Intangible Assets, Net Goodwill The following table reflects the changes in the carrying amount of goodwill: Balance as of June 30, 2020 $ 20,254,309 Adjustments to Trellis' goodwill (14,300 ) Additions due to acquisition of Ample 25,806,518 Goodwill impairment (4,172,000 ) Balance as of December 31, 2020 $ 41,874,527 Additions due to acquisition of Viridian 5,408,884 Additions due to acquisition of 365 Cannabis 14,042,580 Goodwill impairment (14,383,310 ) Balance as of December 31, 2021 $ 46,942,681 Impairment Based on our qualitative assessment of goodwill, we determined it was necessary to perform a quantitative valuation of goodwill as of December 31, 2021 . We determined there were reporting units: the enterprise reporting unit which is comprised of the enterprise software offerings and the non-enterprise reporting unit which is comprised of the non-enterprise software offerings unobservable inputs), which is derived from metrics of publicly traded companies or historically completed transactions of comparable businesses. The selection of comparable businesses is based on the markets in which the reporting units operate giving consideration to risk profiles, size, geography, and diversity of products and services. As such, we believe the current assumptions and estimates utilized are both reasonable and appropriate. During the six months ended December 31, 2020 , primarily as a result of delays in executing on strategic initiatives related to acquisitions completed in 2020, we recorded a $ Enterprise Reporting Unit For the year ended December 31, 2021, no impairment to goodwill was recorded for our enterprise reporting unit as the fair value exceeded the carrying value as of December 31, 2021. To perform our analysis, we applied a % weighting to the market approach and % weighted to the income approach. Non-Enterprise Reporting Unit For the year ended December 31, 2021, primarily due to a continued decline in market valuation and a flattening in the operating results of our non-enterprise reporting unit compared to acquisition assumption, we recorded an impairment expense of $14.4 applied a 25% weighting to the income approach and a 75% weighting to the market approach. Finite-lived Intangible Assets, Net We performed a two step impairment test for the asset groups that had indicators of impairment in the current year under ASC 360 and as a result of this analysis we did not identify any impairment. For the six months ended December 31, 2020, we determined that the carrying value of Solo’s developed technology and trade name exceeded it’s fair value, resulting in an impairment of $2.7 million. Intangible assets as of December 31, 2021 consist of the following Weighted average remaining amortization period (in years) Gross Accumulated Impairment Net carrying Acquired developed technology 3.35 $ 7,138,080 $ (2,815,158) $ — $ 4,322,922 Acquired trade names 3.09 871,920 (286,799) — 585,121 Customer relationships 10.18 17,510,000 (878,250) — 16,631,750 Non-compete agreement 1.75 80,000 (10,000) — 70,000 Total Intangible assets $ 25,600,000 $ (3,990,207) $ — $ 21,609,793 Capitalized software - In-service 2.02 8,807,843 (4,423,887) — 4,383,956 Capitalized software - Work in Progress N/A 3,224,203 — (296,483) 2,927,720 Total Capitalized Software 12,032,046 (4,423,887) (296,483) 7,311,676 Total finite-lived intangible assets $ 37,632,046 $ (8,414,094) $ (296,483) $ 28,921,469 Intangible assets as of December 31, 2020 consist of the following: Weighted average Gross carrying amount Accumulated Impairment Net carrying Acquired developed technology 3.77 $ 8,220,000 $ (1,434,155 ) $ (2,591,920 ) $ 4,193,925 Acquired trade names 5.12 705,000 (97,676 ) (123,080 ) 484,244 Customer relationships 13.04 2,880,000 (169,374 ) — 2,710,626 Total Intangible assets $ 11,805,000 $ (1,701,205 ) $ (2,715,000 ) $ 7,388,795 Capitalized software - In-service 1.62 4,593,512 (1,401,953 ) — 3,191,559 Capitalized software - Work in Progress N/A 734,180 — — 734,180 Total Capitalized Software 5,327,692 (1,401,953 ) — 3,925,739 Total finite-lived intangible assets $ 17,132,692 $ (3,103,158 ) $ (2,715,000 ) $ 11,314,534 We record amortization expense associated with acquired developed technology, acquired trade names, and customer relationships. The amortization expense of all finite-lived intangible assets, which includes capitalized software was $5.6 million, $1.8 million, and $1.3 million for the year ended December 31, 2021, six months ended December 31, 2020, and year ended June 30, 2020, respectively. The amortization expense for the year ended December 31, 2021 includes $ 0.3 As of December 31, 2021, expected amortization expense follows: Acquired Intangible Assets Capitalized Software- In-service 2022 $ 3,445,741 $ 2,722,663 2023 3,131,575 1,144,351 2024 2,801,991 275,884 2025 1,973,934 110,215 2026 1,851,434 59,112 Thereafter 8,405,118 71,731 Tota $ 21,609,793 $ 4,383,956

Fixed assets, net

Fixed assets, net	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Fixed assets, net	Note 7 – Fixed assets, net Fixed assets consisted of the following As of As of 2020 Furniture and computer equipment $ 235,042 $ 131,300 Leasehold improvements 14,064 1,175,556 249,106 1,306,856 Less: accumulated depreciation (95,955 ) (113,423 ) Fixed assets, net $ 153,151 $ 1,193,433 Depreciation expense related to our fixed assets for the year ended December 31, 2021, six months ended December 31 year ended December 31, 2021 lease in Toronto, Canada and wrote off $1.2 million of fixed assets. During the six months ended December 31, 2020, we sold furniture and computer equipment for $ 25,561 with a cost of $ 191,389 and accumulated depreciation of $ 106,555 resulting in a $ 59,273 loss in the consolidated statements of operations for the six months ended December 31, 2020 related to these disposals.

Investments

Investments	12 Months Ended
	Dec. 31, 2021
Investments [Abstract]
Equity Method Investment and Related Party Transaction	N ote - Investments Investment in and License Agreement with Zol Solutions, Inc. On October 7, 2019, we participated in an offering of preferred stock of Zol Solutions, Inc. (“ZolTrain”) along with other investors in which we purchased 203,000 shares of Series Seed Preferred Stock (the “ZolTrain Preferred”) for a purchase price of $250,000, which represents a noncontrolling interest in ZolTrain. The ZolTrain Preferred is convertible into shares o f common stock of ZolTrain at a conversion rate of $1.232 per share at the option of the holder and contains certain anti-dilution protection in the event of certain future issuances of securities by ZolTrain. We are entitled to vote the number of common shares in which the ZolTrain Preferred is convertible into at any meeting of the ZolTrain stockholders. The ZolTrain Preferred also provides us with rights of first refusal with respect to newly issued securities of ZolTrain as well as issued and outstanding securities of ZolTrain that are offered to third parties. In connection with the agreement, one of Akerna's executives was appointed as of members of ZolTrain’s board of directors. At that time, we had determined that We had concluded that the therefore; we account for this investment using the equity method of accounting, which required us to recognize our share of the operations in our results of operations. For year ended December 31, 2021, we recognized equity in loss of investee of $ which During the third quarter of 2021, following the loss of our seat on the Board, we concluded that we should no longer apply the equity method of accounting for the investment in ZolTrain. We determined that we hold an equity security in ZolTrain exist, we estimate the fair value and record an impairment charge if the carrying value of the investment exceeds its estimated fair value. Any impairment charges are recorded in other (expense) income, net, in our consolidated statements of operations. The carrying amount of our investment in ZolTrain was $226,101 as of December 31, 2021 and we did not recognize any impairment on the investment during the current year. Subsequent to our initial investment, we entered into a nonexclusive license/reseller agreement with ZolTrain, effective October 24, 2019, to provide ZolTrain’s online cannabis training platform as a co-branded integration option into our MJ Platform and Leaf Data Syste consideration in the future will mainly depend on whether it becomes probable that such revenue milestones will be achieved. For the year ended December 31, 2021 , the six months ended December 31, 2021, and the year ended June 30, 2020,

Long Term Debt

Long Term Debt	12 Months Ended
	Dec. 31, 2021
Line of Credit Facility [Abstract]
Long Term Debt	Note 9 - Long Term Debt Long-term debt consisted of the following at December 31, 2021: Convertible notes (at fair value) $ 17,305,000 Less: current maturities 13,200,000 Total long-term debt, less current portion $ 4,105,000 Senior Secured Convertible Notes - 2020 On June 8, 2020, we entered into a Securities Purchase Agreement, or SPA, with institutional investors (the "2020 Note Holders"), to sell a new series of senior secured convertible notes (the "2020 Notes"), of Akerna in a private placement to the 2020 Note Holders, in the aggregate principal amount of $17.0 million %, and ranking senior to all outstanding and future indebtedness of Akerna. The 2020 Notes were sold on June 9, 2020, with an original issue discount pursuant to which the Note Holders paid $ per each $ in principal amount of the 2020 Notes. The 2020 Notes do not bear interest except upon the occurrence of an event of default, in which event the applicable rate will be % per annum. Pursuant to the SPA and the 2020 Notes, we and certain of its subsidiaries will enter into a Security and Pledge Agreement (the “Security Agreement”) with the lead investor, in its capacity as collateral agent (in such capacity, the “Collateral Agent”) for all holders of the Notes. The Security Agreement creates a first priority security interest in all of the personal property of the Company and certain of its subsidiaries of every kind and description, tangible or intangible, whether currently owned and existing or created or acquired in the future (the “Collateral”). Under the Security Agreement we agree to certain conditions on its maintenance and use of the Collateral, including but not limited to the location of equipment and inventory, the condition of equipment, the payment of taxes and prevention of liens or encumbrances, the maintenance of insurance, the protection of intellectual property rights, and limitations on transfers and sales. Upon the occurrence of an “Event of Default” under the Security Agreement, the Collateral Agent will have certain rights under the Security Agreement including taking control of the Collateral and, in certain circumstances, selling the Collateral to cover obligations owed to the holders of the 2020 Notes pursuant to its terms. “Event of Default” under the Security Agreement means (i) any defined event of default under any one or more of the transaction documents (including the 2020 Notes), in each instance, after giving effect to any notice, grace, or cure periods provided for in the applicable document, (ii) the failure by us to pay any amounts when due under the 2020 Notes or any other transaction document, or (iii) the breach of any representation, warranty or covenant by the Company under the Security Agreement. The 2020 Notes mature on June 1, 2023, are payable in installments beginning on October 1, 2020, and may not be prepaid. The 2020 Notes are convertible at any time, at the election of the Holders and subject to certain limitations, into shares of common stock at a rate equal to the amount of principal, interest, if any, and unpaid late charges, if any, divided by a conversion price of $ . In connection with the occurrence of an event of default, the Holders of the 2020 Notes will be entitled to convert all or any portion of the 2020 Notes at an alternate conversion price equal to the lower of (i) the conversion price then in effect, or (ii) 80% of the lower of (x) the volume-weighted average price, or VWAP, of the common stock as of the trading day immediately preceding the applicable date of determination, or (y) the quotient of (A) the sum of the VWAP of the common stock for each of the trading days with the lowest VWAP of the common stock during the ( ) consecutive trading day period ending and including the trading day immediately prior to the applicable date of determination, divided by (B) , but not less than $ . We elected to use the fair value option to account for the 2020 Notes. During the six months ended December 31, 2020, we made $1.8 million in principal payments on the 2020 Notes, of which $1.5 million was settled in cash and the remaining $0.3 million was settled in common stock. During the six months ended December 31, 2020, the fair value of the 2020 Notes increased by $1.0 million. Of the adjustment, an increase of $0.1 million resulted from instrument-specific credit risk and was recognized as other comprehensive income and accumulated in equity and an increase of $0.9 million was recognized as current period other expense in our consolidated statement of operations. As of December 31, 2020, the fair value of the 2020 Notes on our consolidated balance sheet was $13.4 million. During the year ended December 31, 2021, up until the date the 2020 Notes were paid in full and replaced by the 2021 Senior Convertible Notes, we made $ million in principal payments on our convertible notes, of which $ million was settled in cash and the remaining $ million was settled in common stock. During the year ended December 31, 2021, the fair value of the Convertible Notes increased by $ million. Of the adjustment, an increase of $ million resulted from instrument-specific credit risk and was recognized as other comprehensive income and accumulated in equity and an increase of $ million was recognized as current period other expense in our consolidated statement of operations. On October 5, 2021, we recognized a gain of $0.2 million in connection with the payoff of the 2020 Notes. Amendment On December 23, 2020, we entered into waivers with the Holders of the 2020 Notes, pursuant to which we and the Holders, separately and not jointly, agreed to waive certain terms and conditions of the 2020 Notes as follows: The Holders irrevocably waived the last sentence of Section 8(a) of the Notes requiring that all installment amounts payable under the 2020 Notes prior to April 1, 2021 be paid in cash pursuant to installment redemptions. We may now elect, in its sole discretion, to pay installment amounts under the 2020 Notes prior to April 1, 2021, by issuing shares of common stock pursuant to installment conversions or by paying cash pursuant to installment redemptions, in each case in accordance with the existing terms of the Convertible Notes. We irrevocably waived the prohibition on acceleration of installment amounts in Section 8(e) of the 2020 Notes solely in relation to the Installment Amount for January 4, 2020, to permit the Holders to accelerate the January 4, 2021 installment amount, in whole or in part, to one We and the Holders agreed that we may irrevocably waive the installment scheduled principal amount for any installment date by setting forth in the installment notice for that installment date an installment amount greater than the installment scheduled principal amount due and payable on the next installment date. Each Holder may then consent to all or a portion of such increased installment amount for such installment date on the trading day immediately prior to such installment date. Any increased amount for an installment amount above the installment scheduled principal amount for such installment date will reduce the principal amount under the 2020 Notes. In relation to the January 4, 2021 installment amount, the Company delivered installment notices to the Holders increasing the installment amount for January 4, 2021, in the aggregate, by $ . Senior Secured Convertible Notes - 2021 On October 5, 2021, we entered into a securities purchase agreement with the two institutional investors that held the Company's 2020 Notes to sell senior secured notes in a private placement (the "Senior Convertible Notes"). The Senior Convertible Notes have an aggregate principal amount of $20.0 million, an aggregate original issue discount of 10%, and rank senior to all our other outstanding and future indebtedness. Approximately $3.3 million of the proceeds from the Senior Convertible Notes were used to payoff the 2020 Notes, which were then to be cancelled. The net proceeds from the issuance of the Senior Convertible Notes was approximately $14.6 million, following the original issue discount and deductions for expenses and paydown of the 2020 Notes. These net proceeds will be used to support Akerna's ongoing growth initiatives and continued investment in current and future technology infrastructur e. The Senior Convertible Notes are convertible into shares of common stock of Akerna at a conversion price of $ per share. The Senior Convertible Notes mature on October 5, 2024 and are to be repaid in monthly installments beginning on January 1, 2022. The Senior Convertible Notes can be repaid in common shares or cash. In connection with the occurrence of an event of default, the Holders of the Senior Convertible Notes Senior Convertible Notes (i) the conversion price then in effect, or (ii) 80 of the lower of (x) the volume-weighted average price, or VWAP, of the common stock as of the trading day immediately preceding the applicable date of determination, or (y) the quotient of (A) the sum of the VWAP of the common stock for each of the two trading days with the lowest VWAP of the common stock during the ten ( 10 ) consecutive trading day period ending and including the trading day immediately prior to the applicable date of determination, divided by (B) two , but not less than $ 0.54 . We have elected to use the fair value option to account for the Senior Convertible Notes Senior Convertible Notes 18.0 Senior Convertible Notes 0.7 Senior Convertible Notes 17.3 During the year ended December 31, 2021, we made no principal payments on our Senior Convertible Notes Paycheck Protection Program Loan On March 27, 2020, former President Trump signed the Coronavirus Aid, Relief and Economic Security (the “CARES Act”), which, among other things, outlined the provisions of the Paycheck Protection Program (the “PPP”). On April 24, 2020, the Paycheck Protection Program and Health Care Enhancement Act, was signed into law increasing funding provided by the CARES Act and on June 5, 2020, the Paycheck Protection Program Flexibility Act extended the program until December 31, 2020. Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all, or a portion of loan granted under the program. Such forgiveness will be determined, subject to limitations, based on the use of loan proceeds for payment of payroll costs and any payments of mortgage interest, rent, and utilities. On April 21, 2020, the Company issued a promissory note to KeyBank National Association (“KeyBank”) in the principal aggregate amount of $2,204,600 (the “PPP Loan”) pursuant to the Paycheck Protection Program under the CARES Act. The PPP Loan had a two-year term bearing interest at a rate of 1% per annum with principal and interest payments of $92,818 to be paid monthly on the 12th of the month beginning 7 months from the date of the PPP Loan. The PPP Loan provides for prepayment of 20% or less of the unpaid principal balance at any time. If more than 20% is prepaid, then all accrued interest must also be paid. In August 2021, the Company submitted its application for 100% loan forgiveness and on September 3, 2021, the loan was 100% forgiven by the Small Business Administration. As a result, the Company recorded a gain on the forgiveness of the loan in the amount of $2,234,730. Maturities of Debt Maturities of our debt as of December 31, 2021 are presented below. Year ending December 31: 2022 $ 13,200,000 2023 6,800,000 Aggregate maturities 20,000,000 Original issue discount on Convertible Notes (2,000,000 ) Unrealized change i n fair value of Convertible Note (695,000 ) Total debt outstanding as of December 31, 2021 $ 17,305,000 Current portion 13,200,000 Noncurrent portion 4,105,000

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Stockholders' Equity	Note 10 - Stockholders’ Equity Common and Preferred Stock We have one 75,000,000 0.0001 We also have 5,000,000 On October 30, 2020, we issued shares, at a price of $ per share, of Akerna common stock in a public offering for gross proceeds of $ million, offset by offering costs of approximately $ million for net proceeds $ million dollars. Warrants In connection with MTech ") MTech sold 5,750,000 10.00 750,000 one one one 11.50 one one A summary of our common stock warrants is presented in the following table: Shares Issuable Weighted-average Weighted Average Aggregate Intrinsic Value Outstanding at June 30, 2020 5,813,804 $ 11.50 3.97 $ — Issued — — — — Exercised — — — — Expired/canceled — — — — Outstanding at December 31, 2020 5,813,804 $ 11.50 3.37 $ — Issued — — — — Exercised — — — — Expired/canceled — — — — Outstanding at December 31, 2021 5,813,804 $ 11.50 2.97 $ — There was no aggregate intrinsic value for the warrants outstanding as of December 31, 2021 and December 31, 2020.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Note 11 - Stock-Based Compensation Restricted Shares and Restricted Stock Units On June 17, 2019, our stockholders considered and approved the 2019 Plan, The Equity Incentive Plan became effective immediately upon the Closing of the Mergers. On June 26, 2020, the stockholders approved an amendment to the Equity Incentive We grant restricted stock units, or RSUs, that are subject to time-based vesting and require continuous employment, typically over a period of from the grant date or the first day of the service period. Prior to the Mergers, MJF had Profit Interest Incentive Plan in place whereby it could grant Profits Interest Units, or PIUs, to employees or consultants and other independent advisors of the Company. PIUs granted under the Profits Interest Plan would generally vest once a year over four years commencing on the date granted or based on specified performance targets. MJF had the right, but not the obligation, to repurchase vested PIUs from holders upon their termination of employment. Unvested PIUs were to be forfeited upon termination of employment. If the holder was terminated for cause, as defined, all vested and unvested units would be forfeited. PIUs repurchased or canceled or forfeited by the award recipient were available for reissuance. Upon completion of the Mergers, the non-vested PIUs were exchanged for and became subject to restricted stock agreements, or Restricted Shares, with varying vesting terms that reflect the vesting conditions applicable to the individual PIUs at the time of the merger. We determined the PIUs represented a profit-sharing compensation arrangement that had value only upon a defined liquidating event. Accordingly, no value was accrued for the PIUs prior to the Mergers on June 17, 2019, which met the definition of a liquidating event. As a result, we recorded a one $ million A summary of our unvested Restricted Shares and activity is presented in the table below: Restricted Shares Restricted Stock Units Total Weighted Average Grant Date Fair Value Unvested as of June 30, 2020 72,313 534,302 606,615 $ 6.56 Granted — 429,974 429,974 4.88 Vested (8,024 ) (157,350 ) (165,374 ) 5.08 Forfeited — (43,906 ) (43,906 ) 6.83 Unvested as of December 31, 2020 64,289 763,020 827,309 $ 6.77 Granted — 447,642 447,642 4.05 Vested (30,559 ) (427,711 ) (458,270 ) 5.55 Forfeited (1,336 ) (99,184 ) (100,520 ) 4.51 Unvested as of 32,394 683,767 716,161 5.47 For the year ended December 31, 2021, six months ended December 31, 2020, and year ended June 30, 2020 we recognized stock-based compensation expens December 31, 2020, $ million The $ million of unrecognized costs as of December 31, 2021 related to Restricted Shares and RSUs will be ratably recognized over an estimated weighted average remaining vesting period of years.

Loss Per Share

Loss Per Share	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Loss Per Share	Note 12 - Loss Per Share D uring the year ended December 31, 2021 -class method to compute net loss per share because we issued securities other than common stock that is economically equivalent to a common share in that the class of stock has the right to participate in dividends should a dividend be declared payable to holders of Akerna common stock. These participating securities were the Exchangeable Shares issued by our wholly owned subsidiary in exchange for interest in Ample. The -class method requires earnings for the period to be allocated between common stock and participating securities based on their respective rights to receive distributed and undistributed earnings. Under the -class method, for periods with net income, basic net income per common share is computed by dividing the net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Net income attributable to common stockholders is computed by subtracting from net income the portion of current period earnings that the participating securities would have been entitled to receive pursuant to their dividend rights had all of the period's earnings been distributed. No such adjustment to earnings is made during periods with a net loss, as the holders of the Exchangeable Shares have no obligation to fund losses. Diluted net loss per common share is calculated under the two-class method by giving effect to all potentially dilutive common stock, including warrants, restricted stock awards, restricted stock units, and shares of common stock issuable upon conversion of our Convertible Notes. We The weighted-average number of shares outstanding used in the computation of diluted earnings per share does not include the effect of potential outstanding common shares that would have been anti-dilutive for the period. The table below details potentially outstanding shares on a fully diluted basis that were not included in the calculation of diluted earnings per share: December 31, 2021 December 31, 2020 Shares issuable upon exchange of Exchangeable Shares 309,286 2,667,349 Warrants 5,813,804 5,813,804 Restricted Stock Units 683,767 694,512 Restricted Stock Awards 32,394 64,289 Shares of common stock issuable in upon conversion of Convertible Notes 12,484,395 1,319,368 Total 19,323,646 10,559,322

Fair Value

Fair Value	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value	Note 13 Contingent Consideration Solo I n connection with our acquisition of Solo, the Solo selling shareholders have the potential to earn the contingent consideration, which is calculated as the lesser of (i) $0.01 per solo*TAGTM and solo*CODETM sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAGTM and solo*CODETM, which is December 1, 2029. We record the fair value of the liability in the consolidated balance sheets under the caption “current contingent consideration” and recognize changes to the liability against earnings or loss each reporting period until settlement. The fair value of the contingent consideration on the date of the acquisition of Solo was $ . In connection with our exercise of the option to acquire the remaining interest in Solo, the selling shareholders agreed to retrospectively and prospectively relieve the contingent consideration obligation. Therefore, the settled value of the contingent consideration was $0. We have recorded a gain of $389,000 on settlement of the contingent consideration liability during the six months ended December 31, 2020 in general and administrative expenses in our consolidated statement of operations. Trellis In connection with our acquisition of Trellis, the Trellis selling shareholders have the potential to earn contingent consideration, which is calculated as five times the annualized revenue of certain customers generated in September 2020. The fair value of the contingent consideration on the date of acquisition of Trellis wa s $ . T as $ . As such, we Ample In addition to the stock and cash consideration, the agreement provides for contingent consideration of up to CAD$ , payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the months after the acquisition date is CAD$ or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000and the amount of Recurring Revenue realized during the twelve months following the acquisition. We record the fair value of the liability in the consolidated balance sheets as contingent consideration payable and recognize changes to the liability against earnings or loss in general and administrative expenses in the consolidated statements of operations. The fair value of the contingent consideration on the date of the acquisition of Ample was $604,000 is $ . We have recorded a gain of $ due the change in the fair value of the contingent consideration during the six months ended December 31, 2020 in general and administrative expenses in our consolidated statement of operations Viridian In connection with our acquisition of Viridian, the Viridian selling shareholders have the potential to earn contingent consideration payable in common stock if Viridian meets certain revenue criteria. The fair value of the contingent consideration on the date of acquisition of Viridian wa s $2,000. T as unchanged at $2,000 . 365 Cannabis In connection with our acquisition of 365 Cannabis, the 365 Cannabis selling shareholders have the potential to earn contingent consideration payable in common stock if certain revenue criteria is met. s $6,300,000. T as unchanged at $6,300,000 . We valued the contingent consideration using a probability-weighted discounted cash flow model, which incorporates inputs that are not observable in the market and thus represents a Level measurement as defined in GAAP. The unobservable inputs utilized for measuring the fair value of the contingent consideration reflect management's own assumptions about the assumptions that market participants would use in valuing the contingent consideration as of the valuation date, as well as our knowledge of specific transactions that effect the calculation. Fair Value Option Election – Convertible Notes We issued Convertible Notes with a principal amount of $ 17.0 15.0 at estimated fair value on a recurring basis at each reporting period date. The remaining estimated fair value adjustment is presented as a single line item within other income (expense) in our consolidated statement of operations under the caption, change in fair value of convertible notes . For the 2020 Notes, which are measured at fair value categorized within Level 3 of the fair value hierarchy, the following is a reconciliation of the fair values from June 30, 2020 Beginning fair value balance on June 30, 2020 $ 14,131,000 Payments on Convertible Notes (1,827,273 ) Change in fair value reported in the statements of operations 961,273 Change in fair value reported in other comprehensive income 133,000 Ending fair value balance - December 31, 2020 $ 13,398,000 Payments on Convertible Notes ( 15,172,727 ) Change in fair value reported in the statements of operations 2,030,904 Change in fair value reported in other comprehensive income (70,000 ) Gain on extinguishment of debt reported on the statement of operations (186,177 ) Ending fair value balance - October 5, 2021 $ — We issued the Senior Secured Notes with a principal amount of $20.0 enior Secured Notes The remaining estimated fair value adjustment is presented as a single line item within other income (expense) in our consolidated statement of operations under the caption, change in fair value of convertible notes . For the Senior Secured Notes, which are measured at fair value categorized within Level 3 ues from October 5, 2021 to : Beginning fair value balance on October 5, 2021 $ 18,000,000 Payments on Convertible Notes — Change in fair value reported in the statements of operations (665,000 ) Change in fair value reported in other comprehensive income (30,000 ) Ending fair value balance - December 31, 2021 $ 17,305,000 The estimated fair value of the Convertible Notes as of December 31, 2021, and December 31, 2020 was computed using a Monte Carlo simulation, which incorporates significant inputs that are not observable in the market, and thus represents a Level 3 measurement as defined by GAAP. The unobservable inputs utilized for measuring the fair value of the Convertible Notes reflects our assumptions about the assumptions that market participants would use in valuing the Convertible Notes as of the issuance date and subsequent reporting period. We determined the fair value by using the following key inputs to the Monte Carlo Simulation Model: Fair Value Assumptions - Convertible Notes December 31, 2021 December 31, 2020 Face value principal payable $ 20,000,000 $ 15,172,272 Original conversion price $ 4.05 $ 11.5 Value of Common Stock $ 1.75 $ 3.24 Expected term (years) 2.8 2.3 Volatility 75 % 77 % Market yield (range) 37.1 % 27.1 to 27.2 % Risk free rate 1.0 % 0.1 % Issue date October 5, 2021 June 9, 2020 Maturity date October 5, 2024 June 1, 2023 Fair Value Measurement – Warrants In connection with MTech Acquisition Corp.'s ("MTech") initial public offering, MTech sold 5,750,000 units at a purchase price of $10.00 per unit, inclusive of 750,000 units sold to the underwriters on February 8, 2018, upon the underwriters’ election to fully exercise their over-allotment option. Each unit consisted of one share of MTech’s common stock and one warrant of MTech (“ MTech Public Warrant Upon completion of the mergers between MTech and MJF on June 17, 2019, as contemplated by the Merger Agreement dated October 10, 2018, as amended ("Mergers"), the MTech Public Warrants and the MTech Private Warrants were converted, respectively, at an exchange ratio of one-for-one to a warrant to purchase one share of Akerna’s common stock with identical terms and conditions as the MTech Public Warrants (“Public Warrant”) and the MTech Private Warrants (“Private Warrant”, collectively with the Public Warrants, “Warrants”) In connection with the completion of the Mergers, we also issued 189,365 common stock purchase warrants upon the cashless exercise of a unit purchase option, which warrants have identical terms to the Public Warrants and are included in references to Public Warrants and Warrants herein. For the Private Warrants classified as derivative liabilities, which are measured at fair value categorized within Level 3 of the fair value hierarchy, the following is a reconciliation of the fair values for the year ended December 31, 2021 and December 31, 2020: Year Ended December 31, 2021 2020 Fair value balance at beginning of period $ 311,376 $ 688,187 Change in fair value reported in the statements of operations (248,198 ) (376,811 ) Fair value balance at end of period $ 63,178 $ 311,376 We utilized a binomial lattice model, which incorporates significant inputs, specifically the expected volatility, that are not observable in the market, and thus represents a Level 3 measurement as defined in GAAP. The unobservable inputs utilized for measuring the fair value of the Private Warrants reflect our estimates regarding the assumptions that market participants would use in valuing the Warrants as of the end of the reporting periods. We record the fair value of the Private Warrants in the consolidated balance sheets under the caption “derivative liability” and recognize changes to the liability against earnings or loss each reporting period. Upon exercise of the Private Warrants, holders will receive a delivery of shares on a net or gross share basis per the terms of the Private Warrants and any exercise will reclassify the Private Warrants, at the time of exercise, to shareholder’s equity to reflect the equity transaction. There are no periodic settlements prior to the holder exercising the Private Warrants. There were no transfers in or out of Level from other levels for the fair value hierarchy. We estimated the fair value by using the following key inputs: Fair Value Assumptions - Private December 31, 2021 December 31, 2020 Number of Private Warrants 225,635 225,635 Original conversion price $ 11.50 $ 11.50 Value of Common Stock $ 1.75 $ 3.24 Expected term (years) 2.46 3.46 Volatility 85.8 % 102.3 % Risk free rate 0.8 % 0.2 %

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 14 - Commitments and Contingencies Operating Leases As of December 31, 2021, we had one facility under a non-cancelable operating leases in Las Vegas. Rent expense for the year ended December 31, 2021, six months ended December 31, 2020 and the year ended June 30, 2020 was $ 157,593 552,861 Future minimum lease payments under these leases are as follows: 2022 $ 252,525 2023 260,100 2024 110,480 Total $ 623,105 During the third quarter of 2021, we reached an agreement to terminate our office lease in Toronto, Canada for a termination fee of approximately $980,000, which is included within the General and Administrative expense line item on the condensed consolidated statement of operations and was paid in full during the year ended December 31, 2021. In connection with the lease termination, we also wrote off certain assets, primarily leasehold improvements, and the resulting loss of $1,045,209 was also recorded in the General and Administrative expense line item on the condensed consolidated statement of operations. During the four quarter of 2020, we reached an agreement to terminate our office lease in Denver, CO. The lease termination agreement included the forfeiture of our $41,250 security deposit and a termination fee of $402,480. The lease termination fee was settled in the first quarter of 2021 by issuing 113,375 shares of common stock, calculated using a VWAP of $3.55/share. Letter-of-Credit As of December 31, 2021 and December 31, 20 20, we had a standby letter-of-credit with a bank in the amount of $ . The standby letter of credit is collateralized by $ of cash, which is classified as restricted cash on our consolidated balance sheets. The beneficiary of the letter-of-credit is an insurance company. Litigation On December 4, 2020, TechMagic USA LLC filed suit against our wholly-owned subsidiary, Solo, in Massachusetts Superior Court, Department Business Litigation, seeking recovery of up to approximately $1.07 million for unpaid invoices pursuant to a Master Services Agreement dated February 5, 2018 by and between TechMagic and Solo. The invoices set forth services that TechMagic USA LLC purports to have provided to Solo regarding development of mobile software applications for MJF and Solo between March and November 2020 totaling approximately $787,000. The suit seeks continued fees under the Master Services Agreement through the end of January 2021. Akerna provided a notice of termination of the Master Services Agreement on November 23, 2020 and the parties dispute the effective date of the termination. Solo disputes the validity of the invoices, in whole or in part, and intends to defend the suit vigorously. Mr. Ashesh Shah, formerly the president of Solo and currently the holder of less than 5% of our issued and outstanding shares of common stock is, to our knowledge, the founder and one of the principal managers of TechMagic USA LLC. As of December 31, 2021 and December 31, 2020, we recognized a loss contingency of $0.5 million and $0.6 million, respectively. On April 2, 2021, TreCom Systems Group, Inc. (“TreCom”) filed suit against Akerna and our wholly-owned subsidiary, MJ Freeway, LLC, in federal District Court for the Eastern District of Pennsylvania, seeking recovery of up to approximately $2 million for services allegedly provided pursuant to a Subcontractor Agreement between MJ Freeway and TreCom. MJ Freeway provided a notice of termination of the operative Subcontractor Agreement on August 4, 2020. MJ Freeway disputes the validity of TreCom’s invoices and the enforceability of the alleged agreement that TreCom submitted to the court. Akerna filed counterclaims against TreCom for breach of contract, a declaratory judgment, commercial disparagement, and defamation. TreCom failed to return Akerna’s intellectual property and issued numerous disparaging statements to of Akerna’s clients. TreCom subsequently filed a motion to dismiss these counterclaims, which was denied by the court . Akern As of December 31, 2021 and December 31, 2020, we recognized a loss contingency of $0.2 million and $0, respectively. On May 21, 2021, our wholly-owned subsidiary, Solo, filed suit against two of Solo’s former directors, Ashesh Shah and Palle Pedersen. Solo seeks recovery for Mr. Shah’s intentional interference with contractual relations, and the defendants’ breaches of various fiduciary duties owed to Solo. Defendant Shah engaged in improper communications with Solo’s customers with the intent that those customers cease their contractual relations with Solo. The defendants also entered into an improper contract with a contractual counter party that the defendants had a conflict of interest with. The defendants have not asserted any counterclaims, and we therefore have not recognized a loss contingency. From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. We will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency might include, for example, estimates of potential damages, outside legal fees and other directly related costs expected to be incurred. As of December 31, 2021, and through the date these consolidated financial statements were issued, there were no other legal proceedings requiring recognition or disclosure in the consolidated financial statements. Employee Benefit Plan We have a 401(k) Plan (the “Plan”) to provide retirement benefits for our employees. Employees may contribute up to a portion of their annual compensation to the Plan, limited to a maximum annual amount as updated annually by the IRS.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Note 15- Income Taxes Since June 17, 2019, we have been the sole owner of MJF, which is a disregarded entity for federal income taxes. Prior to June 17, 2019 MJF was treated as a partnership for U.S income tax purposes. Accordingly, prior to the business combination, our taxable income and losses were reported on the income tax returns of MJF’s members. Therefore, no income tax is provided prior to June 17, 2019. On March 27, 2020 the Coronavirus Aid, Relief and Economic Security Act, or the CARES The accounting for the business combinations of Viridian and 365 Cannabis reflected in the accompanying consolidated financial statements is preliminary and is based upon estimates and assumptions that are subject to change within the measurement period (up to one year from the acquisition date). The measurement period remains open pending the completion of valuation procedures related to the acquired assets and assumed liabilities, intangible assets and income taxes. In April 2020, we were granted a loan, or the PPP Loan, from a lender in the aggregate amount of $ million pursuant to the Paycheck Protection Program under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, which we obtained debt forgiveness on during the year ended December 31, 2021. The following table sets forth the expense or benefit for income taxes: Year Ended December 31, Six Months Ended December 31, Year Ended June 30, 2021 2020 2020 Income tax Current income taxes U.S. federal $ — $ — $ 30,985 U.S. state 5,800 200 — Foreign 6,270 — Total current income taxes $ 12,070 $ 200 $ 30,985 Year Ended December 31, Six Months Ended December 31, Year Ended June 30, 2021 2020 2020 Deferred income tax U.S. federal $ (2,274,295 ) $ — $ — U.S. state — — — Total deferred income tax benefit $ (2,274,295 ) $ — $ — The following table sets forth reconciliations of the income tax expense at the statutory federal income tax rate to actual expense based on income or loss before income taxes: Year Ended December 31, Six Months Ended December 31, June 30, 2021 2020 2020 Income tax expense (benefit) attributable to: Federal $ (6,692,267 ) $ (3,560,998 ) $ (3,255,706 ) State, net of federal benefit (672,148 ) (553,871 ) (862,690 ) Foreign tax rate differential (138,292 ) 29,617 (2,645 ) Permanent differences 2,428,631 1,263,151 312,525 Rate change 54,295 60,220 — Changes in valuation allowance 3,361,603 2,762,081 3,884,440 Provision to return adjustment 273,489 — (45,134 ) Losses from flow-through entity not subject to tax — — — Deferred True-Ups (928,743 ) — — Other adjustments 51,207 — 195 Effective income tax expense (benefit) $ ( 2,262,225 ) $ 200 $ 30,985 December 31, December 31, 2021 2020 Noncurrent deferred tax assets: Employee compensation $ 820,410 $ 679,106 Debt issuance costs 138,778 343,612 Revenue recognition 105,735 — Settlement accrual 146,604 182,896 Fixed assets 242,006 831,196 Federal and state net operating loss 10,673,908 6,337,897 Foreign net operating loss 4,904,857 2,586,671 Other 225,340 27,410 Total deferred tax assets $ 17,257,638 $ 10,988,788 Noncurrent deferred tax liabilities: Fixed assets — — Inta ngibles (6,051,459 ) (2,717,717 ) Deferred tax liabilities $ (6,051,459 ) $ (2,717,717 ) Valuation allowance (11,881,470 ) (8,271,071 ) Deferred taxes after valuation allowance $ (675,291 ) $ — During the year ended December 31, 2021, valuation allowances on deferred tax assets that are not anticipated to be realized increased by $ 3.6 million of which $0.2 million was recorded in purchase accounting and the remainder of $3.4 million was recorded to deferred expense. During the six months ended December 31, 2020, valuation allowances on deferred tax assets that are not anticipated to be realized increased by $5.5 million of which $2.7 million was recorded in purchase accounting and the remainder of $2.8 million was recorded to deferred expense. Our deferred tax valuation allowances are primarily the result of uncertainties regarding the future realization of recorded tax benefits on tax losses. The measurement of deferred tax assets is reduced by a valuation allowance if based upon available evidence, it is more likely than not that the deferred tax assets will not be realized. We have evaluated the realizability of our deferred tax assets in each jurisdiction by assessing the adequacy of expected taxable income, including the reversal of existing temporary differences, historical and projected operating results, and the availability of prudent and feasible tax planning strategies. Based on this analysis, we have determined that the valuation allowances recorded as of December 31, 2021 and December 31, 2020 are appropriate. We have deferred tax assets related to U.S. federal tax and state tax carryforwards for net operating losses in the amount of $44.5 million. The majority of U.S. federal net operating loss carryforwards are carried forward indefinitely. Federal net operating losses generated after 2017 have an indefinite carryforward and are only available to offset 80% taxable income beginning in 2021. U.S. state net operating loss carryforwards expire at various dates of which the majority begin to expire in 2039. We have deferred tax assets related to foreign net operating loss carryforward, which begin to expire in 2034, in the amount of $18.5 million. We are not currently under examination for any of the major jurisdictions where we conduct business as of December 31, 2021, however, all of our tax years remain subject to examination. Our management does not believe there are significant uncertain tax positions in 2021 and as a result we do not expect any cash payments in the next 12 months, however, uncertain tax positions related to potential penalties in the amounts o f $30,000 and $

Revisions of Previously Issued

Revisions of Previously Issued Financial Statements	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Revisions of Previously Issued Financial Statements	Note 16 – Revisions of Previously Issued Financial Statements On June 17, 2019, we completed the Mergers with MTech. Prior to the Mergers, MTech was a special purpose acquisition company and had completed an initial public offering in October 2018, which included the issuances of the MTech Private Warrants in a simultaneous private placement transaction. The MTech Private Warrants were exchanged for our Private Warrants as part of the Mergers and our Private Warrants remain outstanding as of December 31, 2021. We initially accounted for these outstanding Private Warrants as components of equity rather than as derivative liabilities. In light of the Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”) issued by the staff of the SEC on April 12, 2021 (the “SEC Staff Statement”), the Company’s management further evaluated our outstanding warrants under Accounting Standards Codification 815-40, Contracts in Entity’s Own Equity (“ASC 815-40”), which addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s common stock. Based on management’s evaluation and in consultation with the Audit Committee, we concluded that the Company’s Private Warrants are not indexed to the Company’s common stock in the manner contemplated by ASC Section 815-40. reclassify the Private Warrants as derivative liabilities measured at their estimated fair values at the end of each reporting period and recognized changes in the estimated fair value of the derivative instruments from the prior period in the Company’s operating results. The Company's change in accounting for the Private Warrants from components of equity to derivative liabilities has no impact on the Company's current or previously reported cash position. The tables below disclose the effects on the consolidated financial statements included in this Annual Report on Form 10-K: Year Ended June 30, 2020 As report Adjustment As revised Consolidated Statements Change in fair value of derivative liability — 1,962,034 1,962,034 Net loss attributable to Akerna shareholders (15,534,345) 1,962,034 (13,572,311) Net loss per share (1.31) — (1.14) Six Months Ended December 31, 2020 As reported Adjustment As revised Condensed Consolidated Statements of Operations Change in fair value of derivative liability — 746,852 746,852 Net loss attributable to Akerna shareholders ( 16,957,334 746,852 ( 16,210,482 Net loss per share (1.01) — (1.01) As of December 31, 2020 As reported Adjustment As revised Consolidated Balance Sheet Derivative liability — (311,376) (311,376) Total liabilities (19,635,076) (311,376) (19,946,452) Additional paid-in capital 95,090,833 (1,004,450) 94,086,433 Accumulated deficit (57,872,599) 693,074 (57,179,525)

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with GAAP. In September 2020, the Company changed its fiscal year from June 30 to December 31. As a result, this annual report on Form 10-K includes the consolidated financial statements as of December 31, 2021 and December 31, 2020 and for (i) the calendar year ended December 31, 2021, (ii) the transitional six months ended December 31, 2020; and (iii) the fiscal year ended June 30, 2020.
Principles of Consolidation	Principles of Consolidation Our accompanying consolidated financial statements include the accounts of Akerna, our wholly-owned subsidiaries, and those entities in which we otherwise have a controlling financial interest. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the consolidated financial statements and accompanying notes thereto. Our most significant estimates and assumptions are related to the valuation of acquisition-related assets and liabilities, capitalization of internal costs associated with software development, fair value measurements, impairment assessments, loss contingencies, valuation allowance associated with deferred tax assets, stock based compensation expenses, and useful lives of long-lived intangible assets. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents We consider liquid instruments purchased with an original maturity of three months or less to be cash equivalents. There were no cash equivalents as of December 31, 2021, and 2020. We continually monitor our positions with, and the credit quality of, the financial institutions with which we invest. As of the balance sheet date, and periodically throughout the year, we have maintained balances in various operating accounts in excess of federally insured limits.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation.
Foreign Currency	Foreign Currency The functional currency of the Company's non-U.S. operations is the local currency. Monetary assets and liabilities denominated in foreign currencies are translated into U.S. dollars at exchange rates prevailing at the balance sheet dates. Non-monetary assets and liabilities are translated at the historical rates in effect when the assets were acquired or obligations incurred. Revenue and expenses are translated into U.S. dollars using the average rates of exchange prevailing during the period. Translation gains or losses are included as a component of accumulated other comprehensive loss in stockholders' equity. Gains and l
Restricted Cash	Restricted Cash Restricted cash consists of funds that are contractually or legally restricted as to usage or withdrawal and is presented separately from cash and cash equivalents on our consolidated balance sheets. Our restricted cash serves as collateral for a letter of credit.
Accounts Receivable, Net	Accounts Receivable, Net We maintain an allowance for doubtful accounts equal to the estimated uncollectible amounts based on our historical collection experience and review of the current status of trade accounts receivable. Receivables are written-off and charged against the recorded allowance when we have exhausted collection efforts without success. The allowance for doubtful accounts wa s $0.3 million as of December 31, 2021, and 2020, respectively The allowance for doubtful accounts consists of the following activity: Year Ended December 31, Six Months Ended December 31, 2021 2020 Allowance for doubtful accounts, balance at beginning of period $ 153,500 $ 208,422 B ad debt expense 556,890 72,832 Write-off uncollectable accounts (393,306) ( 127,754 ) Allowance for doubtful accounts, balance at end of period $ 317,084 $ 153,500
Concentrations of Credit Risk	Concentrations of Credit Risk We grant credit in the normal course of business to customers in the United States. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk. During the year ended December 31, 2021, the six months ended December 31, 2020 and the year ended June 30, 2 020, one government client accounted for 11%, % and 25% of total revenues, respectively. As of December 31, 2020, two government clients accounted f or a total of 36% of net accounts receivable.
Intangible Assets Acquired through Business Combinations	Intangible Assets Acquired through Business Combinations Intangible assets are amortized over their estimated useful lives. We evaluate the estimated remaining useful life of our intangible assets when events or changes in circumstances indicate an adjustment to the remaining amortization may be needed. We similarly evaluate the recoverability of these assets upon events or changes in circumstances indicate a potential impairment. Recoverability of these assets is measured by comparing the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate. If the undiscounted cash flows used in the test for recoverability are less than the carrying amount of these assets, the carrying amount of such assets is reduced to fair value. We recorded an impairment of $ 2.7 million
Goodwill Impairment Assessment	Goodwill Impairment Assessment Goodwill represents the excess purchase consideration of an acquired business over the fair value of the net tangible and identifiable intangible assets. Goodwill is evaluated for impairment annually on October 31, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate or a significant decrease in expected cash flows. An impairment loss is recognized to the extent that the carrying amount exceeds the reporting unit’s fair value, not to exceed the carrying amount of goodwill. The Company has the option to first assess qualitative factors to determine whether events or circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying amount and determine whether further action is needed. If, after assessing the totality of events or circumstances, the Company determines it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the quantitative impairment test is unnecessary. Due to a continued decline in market conditions and declines in the operating results of our non-enterprise reporting unit, we recognized an impairment to goodwil l of $ million
Software Development Costs	Software Development Costs Costs incurred during the application development stage of a newly developed application and costs we incur to enhance our existing platforms that meet certain criteria are subject to capitalization and subsequent amortization. Capitalized software development costs were approximatel y $5.9 million d urin g the year ended December 31, 2021, $ 2.1 during the ch as payroll
Property and Equipment	Property and Equipment Property and equipment are recorded at cost. Expenditures for major additions and improvements are capitalized. Depreciation and amortization is provided over the estimated useful lives of the related assets using the straight-line method. The estimated useful lives for significant property and equipment categories are generally as follows: Furniture and computer equipment 3 to 7 years Leasehold improvements Lesser of remaining lease term or useful life Repairs and maintenance costs are expensed as incurred.
Warrant Liabilities	Warrant Liabilities Company’s - . As a result, these warrants are precluded from equity classification and are recorded as derivative liabilities. At the end of each reporting period, changes in fair value during the period are recognized within the condensed consolidated statements of operations and comprehensive loss. We will continue to adjust the warrant liability for changes in the fair value until the earlier of a) the exercise or expiration of the warrants or b) the redemption of the warrants, at which time the warrants will be reclassified to additional paid-in capital.
Investment	Investment We
Fair Value of Financial Instruments	Fair Value of Financial Instruments GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, we are required to classify certain assets and liabilities based on the fair value hierarchy, which groups fair value-measured assets and liabilities based upon the following levels of inputs: ● Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; ● Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; ● Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity). The fair value of financial instruments is the amount at which the instrument could be exchanged in a current transaction between willing parties. The carrying values of financial instruments such as accounts receivable, accounts payable and accrued liabilities approximate fair value based on their short maturities. Please refer to Note 13 - Fair Value Measurements for additional
Fair Value Option	Fair Value Option The fair value option provides an election that allows a company to irrevocably elect to record certain financial assets and liabilities at fair value on an instrument-by-instrument basis at initial recognition. We have elected to apply the fair value option to certain convertible notes due to the complexity of the various conversion and settlement options available to both the Note Holders and Akerna. The convertible notes accounted for under the fair value option election are each a debt host financial instrument containing embedded features that would otherwise be required to be bifurcated from the debt-host and recognized as separate derivative liabilities subject to initial and subsequent periodic estimated fair value measurements in accordance with GAAP. Notwithstanding, when the fair value option election is applied to financial liabilities, bifurcation of an embedded derivative is not required, and the financial liability is initially measured at its issue-date estimated fair value and then subsequently remeasured at estimated fair value on a recurring basis as of each reporting period date. The portion of the change in fair value attributed to a change in the instrument-specific credit risk is recognized as a component of other comprehensive income and the remaining amount of the fair value adjustment is recognized as other income (expense) in our consolidated statement of operations. The estimated fair value adjustment is presented in a respective single line item within other income (expense) in the accompanying consolidated statement of operations because the change in fair value of the convertible notes was not attributable to instrument-specific credit risk.
Revenue Recognition	Revenue Recognition See Note 3 for further discussion of our revenue recognition policies.
Cost of Revenue	Cost of Revenue Cost of revenue consists primarily of costs related to providing subscription and other services to our customers, including employee compensation and related expenses for data center operations, customer support and professional services personnel, payments to outside technology service providers, security services, and other tools.
Product Development	Product Development Product development expenses consist primarily of employee-related costs for the design and development of the Company's platform, contractor costs to supplement staff levels, third-party web services, consulting services, and allocated overhead. Product development expenses, other than software development costs qualifying for capitalization, are expensed as incurred.
Sales and Marketing Expenses	Sales and Marketing Expenses Sales and marketing expenses con
General and Administrative Expenses	General and Administrative General and administrative expenses consist primarily of personnel and related costs for our executive, finance, legal, human resources, and administrative personnel, including salaries, b nefits, bonuses, and stock-based compensation; legal, accounting, and other professional service fees; other corporate expenses; information technology costs; restructuring charges such as lease termination costs; and facility costs.
Legal and Other Contingencies	Legal and Other Contingencies From time to time, the Company may be a party to litigation and subject to claims incident to the ordinary course of business, including intellectual property claims, labor and employment claims, breach of contract claims and other asserted and unasserted claims. The Company investigates these claims as they arise and accrues estimates for resolution of legal and other contingencies when losses are probable and estimable.
Stock-Based Compensation	Stock-Based Compensation We measured stock-based compensation based on the fair value of the share-based awards on the date of grant and recognize the related costs on a straight-line basis over the requisite service period, which is generally the vesting period.
Income Taxes	Income Taxes Income taxes are accounted for using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of other assets and liabilities. We provide for income taxes at the current and future enacted tax rates and laws applicable in each taxing jurisdiction. We use a two-step approach for recognizing and measuring tax benefits taken or expected to be taken in a tax return and disclosures regarding uncertainties in income tax positions. We recognize interest and penalties related to income tax matters in selling, general and administrative expenses in the consolidated statement of operations. We recognize deferred tax assets to the extent that its assets are more likely than not to be realized. In making such a determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and results of recent operations. If we determine that we would be able to realize our deferred tax assets in the future in excess of its net recorded amount, we will make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes. As of December 31, 2021, management has applied a valuation allowance to deferred tax assets when it is determined that the benefit from the deferred tax asset will not be able to be utilized in a future period.
Segments	Segments Our chief operating decision maker reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance and information for different revenue streams is not evaluated separately. As such, the Company has one operating segment, and the decision-making group is the senior executive management team. In the following table, we disclose our long-lived assets by geographical location 2021 2020 Long-lived assets: United States $ 32,356 $ 9,994 Canada 5,229 5,074 Total $ 37,585 $ 15,068
Subsequent Events	Subsequent Events The
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements ASU 2016-02 The Financial Accounting Standards Board, or the FASB, has issued new guidance related to the accounting for leases. The new standard establishes a right-of-use model that requires a lessee to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of operations. We ASU 2016-13 The FASB has issued guidance to introduce a new model for recognizing credit losses on financial instruments based on estimated current expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based on historical information, current conditions, and reasonable and supportable forecasts. Following our change in fiscal year-end effective December 31, 2020, the new guidance is effective for us begi ASU 2018-15 The FASB has issued guidance to help entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement (hosting arrangement) by providing guidance for determining when the arrangement includes a software license. ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The guidance (i) provides criteria for determining which implementation costs to capitalize as an asset related to the service contract and which costs to expense, (ii) requires an entity (customer) to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement and (iii) clarifies the presentation requirements for reporting such costs in the entity’s consolidated financial statements. We have adopted this standard effective December 15, 2021, and there is currently no impact to our consolidated financial statements as a result of this guidance. ASU 2019-12 In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which aims to reduce complexity in accounting standards by improving certain areas of U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) without compromising information provided to users of financial statements. ASU 2019-12 is effective for public entities for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. For all other entities, the standard is effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company has adopted ASU 2019-12 effective December 15, 2021 and the adoption of this guidance did not have a significant effect on our consolidated financial statements. ASU 2020-01 The FASB has issued guidance clarifying the interactions between various standards governing investments in equity securities. The new guidance addresses accounting for the transition into and out of the equity method and measurement of certain purchased options and forward contracts to acquire investments. The standard is effective for us for annual and interim periods beginning on January 1, 2022, with early adoption permitted. Adoption of the standard requires changes to be made prospectively. We do not anticipate a significant impact to our consolidated financial statements as a result of this new guidance. ASU 2020-06 In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options and Derivative and Hedging - Contracts in Entity’s Own Equity, which simplifies the accounting for convertible instruments. This guidance eliminates certain models that require separate accounting for embedded conversion features, in certain cases. Additionally, among other changes, the guidance eliminates certain of the conditions for equity classification for contracts in an entity’s own equity. The guidance also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. This guidance is required to be adopted by us in the first quarter of 2023 and must be applied using either a modified or full retrospective approach. We are currently evaluating the impact this guidance will have on our consolidated financial statements. ASU 2021-04 On May 3, 2021, FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Enti We are currently evaluating the impact this guidance will have on our consolidated financial statements. ASU 2021-08 In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which amends the accounting related to contract assets and liabili We are currently evaluating the impact this guidance will have on our consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Schedule of allowance for doubtful accounts	Year Ended December 31, Six Months Ended December 31, 2021 2020 Allowance for doubtful accounts, balance at beginning of period $ 153,500 $ 208,422 B ad debt expense 556,890 72,832 Write-off uncollectable accounts (393,306) ( 127,754 ) Allowance for doubtful accounts, balance at end of period $ 317,084 $ 153,500
Schedule of property and equipment estimated useful lives	Furniture and computer equipment 3 to 7 years Leasehold improvements Lesser of remaining lease term or useful life
Schedule of long-lived assets by geographical location	2021 2020 Long-lived assets: United States $ 32,356 $ 9,994 Canada 5,229 5,074 Total $ 37,585 $ 15,068

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Summarizes revenue disaggregation	Year Ended December 31, 2021 Six Months Year Ended June 30, 2020 (1) Government $ 3,258 $ 1,939 $ 4,906 Non-government 17,427 5,886 7,667 $ 20,685 $ 7,825 $ 12,573 (1) As noted above, prior periods have not been adjusted for the adoption of ASC 606 and are presented in accordance with historical accounting guidance in effect for those periods.
Summarizes adjusted for the adoption of ASC 606	Year Ended December 31, 2021 Six Months Ended December 31, 2020 Year Ended June 30, 2020 United States $ 15,800 $ 5,212 $ 12,573 Canada 4,885 2,613 — $ 20,685 $ 7,825 $ 12,573
Summarizes deferred contract cost activity	As of January 1, 2021 Additions Amortized costs (1) As of December 31, 2021 Deferred contract costs $ 228 512 (479 ) $ 261 ( ) Includes contract costs amortized to sales and marketing expense during the period.
Summarizes deferred revenue activity	As of January 1, 2021 Net additions Revenue recog nize As of December 31, 2021 Deferred revenue $ 844 12,657 9,375 $ 4,126

Acquisitions (Tables)

Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2021
Business Acquisition [Line Items]
Schedule of pro forma financial information	Six Months Ended December 31, Year Ended June 30, 2020 2020 Revenue $ 14,026 $ 27,523 Net loss $ ( ) $ (20,250 )
Trellis Solutions, Inc. [Member]
Business Acquisition [Line Items]
Schedule of estimated acquisition date fair value of consideration	Common shares issued $ 2,531 Cont ingent consid 998 Total estimated fair value of consideration $ 3,529
Schedule of preliminary estimated fair values of assets acquired and liabilities	Cash $ 21 Accounts receivable, net 91 Other assets 6 Acquired technology 210 Acquired trade name 80 Customer relationships 220 Goodwill 3,216 Accounts payable and accrued expenses (284 ) Deferred revenue (31 ) Net assets acquired $ 3,529
Solo Sciences, Inc. [Member]
Business Acquisition [Line Items]
Schedule of estimated acquisition date fair value of consideration	Common shares issued $ 17,550 Contingent considerat 389 Total estimated fair value of consideration $ 17,939
Schedule of preliminary estimated fair values of assets acquired and liabilities	Cash $ 101 Prepaid expenses and other assets 22 Furniture, fixtures, and equipment 2 Acquired technology 7,160 Acquired trade name 340 Goodwill 17,025 Accounts payable and accrued liabilities (1,158 ) Fair value of noncontrolling interests (5,553 ) Net assets acquired $ 17,939
Ample Organics [Member]
Business Acquisition [Line Items]
Schedule of estimated acquisition date fair value of consideration	Preliminary Exchangeable shares issued $ 25,203 Cash 5,724 Contingent consideration 604 Total estimated fair value of consideration transferred $ 31,531
Schedule of preliminary estimated fair values of assets acquired and liabilities	Preliminary Cash $ 445 Accounts receivable 917 Prepaid expenses and other current assets 595 Acquired technology 850 Customer relationships 2,660 Acquired trade name 285 Goodwill 25,806 Furniture, fixtures and equipment 1,327 Accounts payable and accrued expenses (805 ) Deferred revenue (549 ) Net assets acquired $ 31,531
Viridian Sciences Inc. [Member]
Business Acquisition [Line Items]
Schedule of estimated acquisition date fair value of consideration	Preliminary Fair Value Shares issued $ 6,186 Contingent co nsidera 2 Total preliminary fair value of consideration transferred $ 6,188
Schedule of preliminary estimated fair values of assets acquired and liabilities	Preliminary Fair Value Accounts receivable 556 Prepaid expenses and other current assets 148 Capitalized software 423 Acquired technology 470 Customer relationships 820 Acquired trade name 20 Goodwill 5,408 Accounts payable and accrued expenses (350 ) Deferred tax liabilities (307 ) Deferred revenue (1,000 ) Net assets acquired $ 6,188
365 Cannabis [Member]
Business Acquisition [Line Items]
Schedule of estimated acquisition date fair value of consideration	Preliminary Fair Value Shares issued $ 12,000 Cash 5,542 Contingent co nsidera 6,300 Total preliminary fair value of consideration transferred $ 23,842
Schedule of preliminary estimated fair values of assets acquired and liabilities	Preliminary Fair Value Cash 527 Accounts receivable 486 Prepaid expenses and other current asset 261 Fixed Assets 93 Non-compete agreement 80 Acquired technology 1,040 Customer relationships 13,810 Acquired trade name 270 Goodwill 14,043 Accounts payable and accrued expenses (826 ) Deferred tax liabilities (2,642 ) Deferred revenue (3,300 ) Net assets acquired $ 23,842

Balance Sheet Disclosures (Tabl

Balance Sheet Disclosures (Tables)	12 Months Ended
	Dec. 31, 2021
Balance Sheet Disclosures [Abstract]
Schedule of prepaid expenses and other current assets	As of December 31, 2021 2020 Software and technology $ 687,740 $ 480,651 Professional services, dues and subscriptions 546,126 826,195 Insurance 264,097 243,222 Deferred contract costs 260,899 227,718 Unbilled receivable 506,984 612,446 Other 117,918 Total prepaid expenses and other current assets $ 2,383,764 $ 2,458,727
Schedule of Accounts payable, accrued expenses and other current liabilities	As of December 31 2021 2020 Accounts payable $ 1,943,457 $ 513,610 Professional fees 319,590 233,667 Sales taxes 360,361 216,367 Compensation 1,123,467 311,379 Contractors 1,288,730 538,618 Settlements and legal 681,045 831,232 Other 346,870 543,703 Total accounts payable, accrued expenses and other current liabilities $ 6,063,520 $ 3,188,576

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of changes in the carrying amount of goodwill	Balance as of June 30, 2020 $ 20,254,309 Adjustments to Trellis' goodwill (14,300 ) Additions due to acquisition of Ample 25,806,518 Goodwill impairment (4,172,000 ) Balance as of December 31, 2020 $ 41,874,527 Additions due to acquisition of Viridian 5,408,884 Additions due to acquisition of 365 Cannabis 14,042,580 Goodwill impairment (14,383,310 ) Balance as of December 31, 2021 $ 46,942,681
Schedule of intangible assets	Weighted average remaining amortization period (in years) Gross Accumulated Impairment Net carrying Acquired developed technology 3.35 $ 7,138,080 $ (2,815,158) $ — $ 4,322,922 Acquired trade names 3.09 871,920 (286,799) — 585,121 Customer relationships 10.18 17,510,000 (878,250) — 16,631,750 Non-compete agreement 1.75 80,000 (10,000) — 70,000 Total Intangible assets $ 25,600,000 $ (3,990,207) $ — $ 21,609,793 Capitalized software - In-service 2.02 8,807,843 (4,423,887) — 4,383,956 Capitalized software - Work in Progress N/A 3,224,203 — (296,483) 2,927,720 Total Capitalized Software 12,032,046 (4,423,887) (296,483) 7,311,676 Total finite-lived intangible assets $ 37,632,046 $ (8,414,094) $ (296,483) $ 28,921,469 Weighted average Gross carrying amount Accumulated Impairment Net carrying Acquired developed technology 3.77 $ 8,220,000 $ (1,434,155 ) $ (2,591,920 ) $ 4,193,925 Acquired trade names 5.12 705,000 (97,676 ) (123,080 ) 484,244 Customer relationships 13.04 2,880,000 (169,374 ) — 2,710,626 Total Intangible assets $ 11,805,000 $ (1,701,205 ) $ (2,715,000 ) $ 7,388,795 Capitalized software - In-service 1.62 4,593,512 (1,401,953 ) — 3,191,559 Capitalized software - Work in Progress N/A 734,180 — — 734,180 Total Capitalized Software 5,327,692 (1,401,953 ) — 3,925,739 Total finite-lived intangible assets $ 17,132,692 $ (3,103,158 ) $ (2,715,000 ) $ 11,314,534
Schedule of capitalized software and purchased intangible assets	Acquired Intangible Assets Capitalized Software- In-service 2022 $ 3,445,741 $ 2,722,663 2023 3,131,575 1,144,351 2024 2,801,991 275,884 2025 1,973,934 110,215 2026 1,851,434 59,112 Thereafter 8,405,118 71,731 Tota $ 21,609,793 $ 4,383,956

Fixed assets, net (Tables)

Fixed assets, net (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Schedule of fixed assets, net	As of As of 2020 Furniture and computer equipment $ 235,042 $ 131,300 Leasehold improvements 14,064 1,175,556 249,106 1,306,856 Less: accumulated depreciation (95,955 ) (113,423 ) Fixed assets, net $ 153,151 $ 1,193,433

Long Term Debt (Tables)

Long Term Debt (Tables)	12 Months Ended
	Dec. 31, 2021
Line of Credit Facility [Abstract]
Schedule of long-term debt	Convertible notes (at fair value) $ 17,305,000 Less: current maturities 13,200,000 Total long-term debt, less current portion $ 4,105,000
Schedule of maturities of outstanding long-term debt obligations in subsequent years	Year ending December 31: 2022 $ 13,200,000 2023 6,800,000 Aggregate maturities 20,000,000 Original issue discount on Convertible Notes (2,000,000 ) Unrealized change i n fair value of Convertible Note (695,000 ) Total debt outstanding as of December 31, 2021 $ 17,305,000 Current portion 13,200,000 Noncurrent portion 4,105,000

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Schedule of stock warrants	Shares Issuable Weighted-average Weighted Average Aggregate Intrinsic Value Outstanding at June 30, 2020 5,813,804 $ 11.50 3.97 $ — Issued — — — — Exercised — — — — Expired/canceled — — — — Outstanding at December 31, 2020 5,813,804 $ 11.50 3.37 $ — Issued — — — — Exercised — — — — Expired/canceled — — — — Outstanding at December 31, 2021 5,813,804 $ 11.50 2.97 $ —

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
Schedule of stock warrants	Restricted Shares Restricted Stock Units Total Weighted Average Grant Date Fair Value Unvested as of June 30, 2020 72,313 534,302 606,615 $ 6.56 Granted — 429,974 429,974 4.88 Vested (8,024 ) (157,350 ) (165,374 ) 5.08 Forfeited — (43,906 ) (43,906 ) 6.83 Unvested as of December 31, 2020 64,289 763,020 827,309 $ 6.77 Granted — 447,642 447,642 4.05 Vested (30,559 ) (427,711 ) (458,270 ) 5.55 Forfeited (1,336 ) (99,184 ) (100,520 ) 4.51 Unvested as of 32,394 683,767 716,161 5.47

Loss Per Share (Tables)

Loss Per Share (Tables)	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Schedule of diluted earnings per share	December 31, 2021 December 31, 2020 Shares issuable upon exchange of Exchangeable Shares 309,286 2,667,349 Warrants 5,813,804 5,813,804 Restricted Stock Units 683,767 694,512 Restricted Stock Awards 32,394 64,289 Shares of common stock issuable in upon conversion of Convertible Notes 12,484,395 1,319,368 Total 19,323,646 10,559,322

Fair Value (Tables)

Fair Value (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Schedule of reconciliation of fair values	Beginning fair value balance on June 30, 2020 $ 14,131,000 Payments on Convertible Notes (1,827,273 ) Change in fair value reported in the statements of operations 961,273 Change in fair value reported in other comprehensive income 133,000 Ending fair value balance - December 31, 2020 $ 13,398,000 Payments on Convertible Notes ( 15,172,727 ) Change in fair value reported in the statements of operations 2,030,904 Change in fair value reported in other comprehensive income (70,000 ) Gain on extinguishment of debt reported on the statement of operations (186,177 ) Ending fair value balance - October 5, 2021 $ —
Schedule of fair value by using key inputs	Fair Value Assumptions - Convertible Notes December 31, 2021 December 31, 2020 Face value principal payable $ 20,000,000 $ 15,172,272 Original conversion price $ 4.05 $ 11.5 Value of Common Stock $ 1.75 $ 3.24 Expected term (years) 2.8 2.3 Volatility 75 % 77 % Market yield (range) 37.1 % 27.1 to 27.2 % Risk free rate 1.0 % 0.1 % Issue date October 5, 2021 June 9, 2020 Maturity date October 5, 2024 June 1, 2023
Private Warrant [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Schedule of reconciliation of fair values	Beginning fair value balance on October 5, 2021 $ 18,000,000 Payments on Convertible Notes — Change in fair value reported in the statements of operations (665,000 ) Change in fair value reported in other comprehensive income (30,000 ) Ending fair value balance - December 31, 2021 $ 17,305,000 Fair Value Assumptions - Private December 31, 2021 December 31, 2020 Number of Private Warrants 225,635 225,635 Original conversion price $ 11.50 $ 11.50 Value of Common Stock $ 1.75 $ 3.24 Expected term (years) 2.46 3.46 Volatility 85.8 % 102.3 % Risk free rate 0.8 % 0.2 %
Schedule of fair value by using key inputs	Year Ended December 31, 2021 2020 Fair value balance at beginning of period $ 311,376 $ 688,187 Change in fair value reported in the statements of operations (248,198 ) (376,811 ) Fair value balance at end of period $ 63,178 $ 311,376

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Schedule of future minimum lease payments	2022 $ 252,525 2023 260,100 2024 110,480 Total $ 623,105

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Schedule of expense or (benefit) for income taxes	Year Ended December 31, Six Months Ended December 31, Year Ended June 30, 2021 2020 2020 Deferred income tax U.S. federal $ (2,274,295 ) $ — $ — U.S. state — — — Total deferred income tax benefit $ (2,274,295 ) $ — $ — Year Ended December 31, Six Months Ended December 31, Year Ended June 30, 2021 2020 2020 Income tax Current income taxes U.S. federal $ — $ — $ 30,985 U.S. state 5,800 200 — Foreign 6,270 — Total current income taxes $ 12,070 $ 200 $ 30,985
Schedule of statutory federal income tax rate to actual rates based on income or loss before income taxes	Year Ended December 31, Six Months Ended December 31, June 30, 2021 2020 2020 Income tax expense (benefit) attributable to: Federal $ (6,692,267 ) $ (3,560,998 ) $ (3,255,706 ) State, net of federal benefit (672,148 ) (553,871 ) (862,690 ) Foreign tax rate differential (138,292 ) 29,617 (2,645 ) Permanent differences 2,428,631 1,263,151 312,525 Rate change 54,295 60,220 — Changes in valuation allowance 3,361,603 2,762,081 3,884,440 Provision to return adjustment 273,489 — (45,134 ) Losses from flow-through entity not subject to tax — — — Deferred True-Ups (928,743 ) — — Other adjustments 51,207 — 195 Effective income tax expense (benefit) $ ( 2,262,225 ) $ 200 $ 30,985 December 31, December 31, 2021 2020 Noncurrent deferred tax assets: Employee compensation $ 820,410 $ 679,106 Debt issuance costs 138,778 343,612 Revenue recognition 105,735 — Settlement accrual 146,604 182,896 Fixed assets 242,006 831,196 Federal and state net operating loss 10,673,908 6,337,897 Foreign net operating loss 4,904,857 2,586,671 Other 225,340 27,410 Total deferred tax assets $ 17,257,638 $ 10,988,788 Noncurrent deferred tax liabilities: Fixed assets — — Inta ngibles (6,051,459 ) (2,717,717 ) Deferred tax liabilities $ (6,051,459 ) $ (2,717,717 ) Valuation allowance (11,881,470 ) (8,271,071 ) Deferred taxes after valuation allowance $ (675,291 ) $ —

Revisions of Previously Issue_2

Revisions of Previously Issued Financial Statements (Tables)	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of reclassifications	Year Ended June 30, 2020 As report Adjustment As revised Consolidated Statements Change in fair value of derivative liability — 1,962,034 1,962,034 Net loss attributable to Akerna shareholders (15,534,345) 1,962,034 (13,572,311) Net loss per share (1.31) — (1.14) Six Months Ended December 31, 2020 As reported Adjustment As revised Condensed Consolidated Statements of Operations Change in fair value of derivative liability — 746,852 746,852 Net loss attributable to Akerna shareholders ( 16,957,334 746,852 ( 16,210,482 Net loss per share (1.01) — (1.01) As of December 31, 2020 As reported Adjustment As revised Consolidated Balance Sheet Derivative liability — (311,376) (311,376) Total liabilities (19,635,076) (311,376) (19,946,452) Additional paid-in capital 95,090,833 (1,004,450) 94,086,433 Accumulated deficit (57,872,599) 693,074 (57,179,525)

Description of Business, Liqu_2

Description of Business, Liquidity, and Capital Resources (Details) - USD ($)	Oct. 05, 2021	Oct. 05, 2021	Jan. 04, 2021	Jun. 09, 2020	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2020	Aug. 05, 2021	Jul. 23, 2021
Debt Instrument [Line Items]
Loss from operations					$ (15,739,677)		$ (33,355,319)		$ (17,271,851)
Cash in operations					(8,705,738)		(8,167,904)		(14,347,652)
Maturity date, description		The Senior Convertible Notes mature on October 5, 2024 and are to be repaid in monthly installments beginning on January 1, 2022. The Senior Convertible Notes can be repaid in common shares or cash.
Aggregate principal amount										$ 20,000,000
Installment amount			$ 2,062,500
Issuance of common stock					11,032,380		$ 1,900,000
Issuance of common stock, shares							556,388
Common stock value issued											$ 25,000,000
Conversion price		$ 4.05
Conversion amount					$ 4,798,271		$ 18,038,944
Default interest rate		10.00%
Proceeds from the senior convertible notes	$ 3,300,000	$ 3,300,000		$ 1,000
Working capital deficit							10,900,000
Cash							13,900,000
Operating Expense [Member]
Debt Instrument [Line Items]
Loss from operations						$ 17,300,000	33,400,000	$ 15,700,000
Cash in operations						$ 14,300,000	$ 8,200,000	$ 8,700,000
Senior Debt Obligations [Member]
Debt Instrument [Line Items]
Conversion amount		5,000,000
Proceeds from the senior convertible notes		$ 14,600,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Accounting Policies [Abstract]
Allowance for doubtful accounts, beginning balance	$ 208,422	$ 153,500
Additions:
Bad debt expense	72,832	556,890
Deductions:
Write-off uncollectable accounts	(127,754)	(393,306)
Allowance for doubtful accounts, ending balance	$ 153,500	$ 317,084

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details 1)	12 Months Ended
	Dec. 31, 2021
Schedule of property and equipment estimated useful lives [Line Items]
Leasehold improvements	Lesser of remaining lease term or useful life
Maximum [Member]
Schedule of property and equipment estimated useful lives [Line Items]
Furniture and computer equipment useful life	7 years
Minimum [Member]
Schedule of property and equipment estimated useful lives [Line Items]
Furniture and computer equipment useful life	3 years

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details 2) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Long-Lived Assets [Line Items]
Total long-lived assets	$ 37,585	$ 15,068
United States
Long-Lived Assets [Line Items]
Total long-lived assets	32,356	9,994
Canada
Long-Lived Assets [Line Items]
Total long-lived assets	$ 5,229	$ 5,074

Summary of Significant Accoun_7

Summary of Significant Accounting Policies (Details Textual)	6 Months Ended	12 Months Ended
	Dec. 31, 2020USD ($)Customers	Dec. 31, 2021USD ($)Customers	Dec. 31, 2020USD ($)Customers	Jun. 30, 2020USD ($)Customers
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for doubtful accounts	$ 200,000	$ 300,000	$ 200,000
Software development costs		5,900,000	2,100,000	$ 3,100,000
performance obligations		16.6
Impairment of intangible assets			4,200,000
Revenue recognized		$ (9,375,000)
Impairment expense			$ 2,700,000
Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Expected useful life			5 years
Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Expected useful life			2 years
Total Revenues [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of customer | Customers	1	1		1
Total Revenues [Member] | Customer one [Member] | Revenue from Rights Concentration Risk [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk percentage	14.00%	11.00%		25.00%
Net Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of customer | Customers			2
Net Accounts Receivable [Member] | Customer two [Member] | Customer Concentration Risk [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk percentage			36.00%

Revenue (Details)

Revenue (Details) - USD ($)	6 Months Ended		12 Months Ended
	Dec. 31, 2020	[1]	Dec. 31, 2021	Jun. 30, 2020
Disaggregation of Revenue [Line Items]
Revenue disaggregation	$ 7,825		$ 20,685,000	$ 12,573
Government [Member]
Disaggregation of Revenue [Line Items]
Revenue disaggregation	1,939		3,258,000	4,906
Non-Government [Member]
Disaggregation of Revenue [Line Items]
Revenue disaggregation	$ 5,886		$ 17,427,000	$ 7,667
[1]	As noted above, prior periods have not been adjusted for the adoption of ASC 606 and are presented in accordance with historical accounting guidance in effect for those periods.

Revenue (Details 1)

Revenue (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020		Jun. 30, 2020
Disaggregation of Revenue [Line Items]
Adjusted for adoption	$ 20,685,000	$ 7,825,000	[1]	$ 12,573
United States
Disaggregation of Revenue [Line Items]
Adjusted for adoption	15,800,000	5,212,000	[1]	12,573
Canada
Disaggregation of Revenue [Line Items]
Adjusted for adoption	$ 4,885,000	$ 2,613,000
[1]	As noted above, prior periods have not been adjusted for the adoption of ASC 606 and are presented in accordance with historical accounting guidance in effect for those periods.

Revenue (Details 2)

Revenue (Details 2) $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)
Movement in Deferred Revenue [Roll Forward]
Deferred revenue Beginning Balance	$ 844
Net additions	12,657
Revenue recognized	(9,375)
Deferred revenue Ending Balance	$ 4,126

Revenue (Details 3)

Revenue (Details 3)	12 Months Ended
	Dec. 31, 2021USD ($)
Revenue from Contract with Customer [Abstract]
Deferred contract costs Beginning Balance	$ 228
Additions	512,000
Amortized costs	479,000
Deferred contract costs Ending Balance	$ 261,000

Revenue (Details Textual)

Revenue (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Jul. 06, 2020	Jul. 02, 2020
Revenue from Contract with Customer [Abstract]
Accumulated deficit	$ (88,508,236)	$ (57,179,525)		$ 0.2
Deferral of contract costs	200,000
Revenue recognized	20,700,000
Deferred revenue	3,543,819	$ 843,900	$ 0.7
Deferred Revenue, Recognized	$ 11,100,000

Acquisitions (Details)

Acquisitions (Details) - USD ($)	Apr. 01, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Total estimated fair value of consideration		$ 0
Total preliminary fair value of consideration transferred	$ 6,188
Viridian Sciences Inc. [Member]
Business Acquisition [Line Items]
Common shares issued	6,186
Contingent consideration	$ 2

Acquisitions (Details 1)

Acquisitions (Details 1) - USD ($)	Dec. 31, 2021	Apr. 01, 2021	Dec. 31, 2020	Jun. 30, 2020
Business Acquisition [Line Items]
Cash	$ 527,346		$ 445,269
Accounts receivable, net	1,041,912		917,205	77,505
Prepaid expenses and other current assets	408,973		596,233	27,860
Deferred tax liabilities	(2,949,586)
Deferred revenue	$ (4,301,514)		$ (549,311)	$ (31,220)
Viridian Sciences Inc. [Member]
Business Acquisition [Line Items]
Accounts receivable, net		$ 556
Prepaid expenses and other current assets		148
Capitalized software		423
Acquired technology		470
Acquired trade name		20
Customer relationships		820
Goodwill		5,408
Accounts payable and accrued expenses		(350)
Deferred tax liabilities		(307)
Deferred revenue		(1,000)
Net assets acquired		$ 6,188

Acquisitions (Details 2)

Acquisitions (Details 2) - USD ($)	Oct. 01, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Total estimated fair value of consideration		$ 0
365 Cannabis [Member]
Business Acquisition [Line Items]
Common shares issued	$ 12,000
Cash	5,542
Contingent consideration	6,300
Total estimated fair value of consideration	$ 23,842

Acquisitions (Details 3)

Acquisitions (Details 3) - USD ($)	Dec. 31, 2021	Oct. 01, 2021	Dec. 31, 2020	Jun. 30, 2020
Business Acquisition [Line Items]
Cash	$ 527,346		$ 445,269
Accounts receivable	1,041,912		917,205	77,505
Prepaid expenses and other assets	408,973		596,233	27,860
Deferred tax liabilities	(2,949,586)
Deferred revenue	$ (4,301,514)		$ (549,311)	$ (31,220)
365 Cannabis [Member]
Business Acquisition [Line Items]
Cash		$ 527
Accounts receivable		486
Prepaid expenses and other assets		261
Fixed Assets		93
Non-compete agreement		80
Acquired technology		1,040
Customer relationships		13,810
Acquired trade name		270
Goodwill		14,043
Accounts payable and accrued expenses		(826)
Deferred tax liabilities		(2,642)
Deferred revenue		(3,300)
Net assets acquired		$ 23,842

Acquisitions (Details 4)

Acquisitions (Details 4) - USD ($)	Apr. 08, 2020	Dec. 31, 2020
Business Acquisition [Line Items]
Total estimated fair value of consideration		$ 0
Trellis Solutions, Inc [Member]
Business Acquisition [Line Items]
Common shares issued	$ 2,531
Contingent consideration	998
Total estimated fair value of consideration	$ 3,529

Acquisitions (Details 5)

Acquisitions (Details 5) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2020	Apr. 08, 2020
Business Acquisition [Line Items]
Cash	$ 527,346	$ 445,269
Accounts receivable, net	1,041,912	917,205	77,505
Prepaid expenses and other assets	408,973	596,233	27,860
Deferred revenue	$ (4,301,514)	$ (549,311)	$ (31,220)
Trellis Solutions, Inc [Member]
Business Acquisition [Line Items]
Cash				$ 21
Accounts receivable, net				91
Prepaid expenses and other assets				6
Acquired technology				210
Customer relationships				220
Acquired trade name				80
Goodwill				3,216
Accounts payable and accrued expenses				(284)
Deferred revenue				(31)
Net assets acquired				$ 3,529

Acquisitions (Details 6)

Acquisitions (Details 6) - USD ($)	Apr. 08, 2020	Dec. 31, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Total estimated fair value of consideration			$ 0
Solo Sciences, Inc. [Member]
Business Acquisition [Line Items]
Common shares issued	$ 17,550
Contingent consideration	389
Total estimated fair value of consideration	$ 17,939	$ 0

Acquisitions (Details 7)

Acquisitions (Details 7) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2020	Jan. 15, 2020
Business Acquisition [Line Items]
Cash	$ 527,346	$ 445,269
Accounts receivable, net	1,041,912	917,205	77,505
Prepaid expenses and other assets	408,973	596,233	27,860
Deferred revenue	$ (4,301,514)	$ (549,311)	$ (31,220)
Solo Sciences, Inc. [Member]
Business Acquisition [Line Items]
Cash				$ 101
Prepaid expenses and other assets				22
Furniture, fixtures, and equipment				2
Acquired technology				7,160
Acquired trade name				340
Goodwill				17,025
Accounts payable and accrued expenses				(1,158)
Fair value of noncontrolling interests				(5,553)
Net assets acquired				$ 17,939

Acquisitions (Details 8)

Acquisitions (Details 8) - USD ($)	Jul. 07, 2020	Dec. 31, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Total estimated fair value of consideration			$ 0
Ample Organics [Member]
Business Acquisition [Line Items]
Common shares issued	$ 25,203
Cash	5,724
Contingent consideration	604
Total estimated fair value of consideration	$ 31,531	$ 0

Acquisitions (Details 9)

Acquisitions (Details 9) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Jul. 07, 2020	Jun. 30, 2020
Business Acquisition [Line Items]
Cash	$ 527,346	$ 445,269
Accounts receivable, net	1,041,912	917,205		77,505
Prepaid expenses and other assets	408,973	596,233		27,860
Deferred revenue	$ (4,301,514)	$ (549,311)		$ (31,220)
Ample Organics [Member]
Business Acquisition [Line Items]
Cash			$ 445
Accounts receivable, net			917
Prepaid expenses and other assets			595
Acquired technology			850
Customer relationships			2,660
Acquired trade name			285
Goodwill			25,806
Furniture, fixtures, and equipment			1,327
Accounts payable and accrued expenses			(805)
Deferred revenue			(549)
Net assets acquired			$ 31,531

Acquisitions (Details 10)

Acquisitions (Details 10) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2020
Business Combinations [Abstract]
Revenues	$ 28,847	$ 14,026	$ 27,523
Net loss	$ (31,423)	$ (17,650)	$ (20,250)

Acquisitions (Details Textual)

Acquisitions (Details Textual)	Oct. 01, 2021USD ($)shares	Oct. 01, 2021USD ($)shares	Apr. 01, 2021USD ($)shares	Jul. 07, 2020USD ($)	Apr. 11, 2020USD ($)	Jan. 30, 2020USD ($)	Jan. 15, 2020USD ($)$ / sharesshares	Dec. 31, 2021USD ($)	Sep. 30, 2021USD ($)	Dec. 31, 2020USD ($)$ / sharesshares	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)$ / sharesshares	Jun. 30, 2020USD ($)	Dec. 31, 2021CAD ($)shares	Dec. 31, 2021USD ($)$ / sharesshares	Sep. 01, 2020shares	Jul. 31, 2020shares	Apr. 08, 2020USD ($)$ / sharesshares
Business Acquisition [Line Items]
Common stock, shares issued | shares			1				1,950,000			31,001,884		31,001,884		31,001,884	31,001,884		800,000
Convertible into shares of common stock per share | $ / shares							$ 9
Amortization expense of intangible assets											$ 5,600,000	$ 1.8	$ 1,300,000
Revenues		$ 2,400,000								$ 7,824,784	20,684,974		12,573,276
Net income (loss)								$ 400,000		$ (16,210,481)	(31,328,711)		(13,572,311)
Preferred stock, par value | $ / shares										$ 0.0001		$ 0.0001			$ 0.0001
Preferred stock, liquidation preference per share | $ / shares															$ 1
Exchangeable shares | shares																627,225
Exchangeable shares issued | shares										309,286		309,286				4,798,271
Assets and liability acquired															$ 14,300
General and administrative expenses											1.1	$ 1.8
Goodwill and intangible assets impairment											$ 14.4
Contingent consideration															6,300,000
Common stock issued in business combinations													20,081,466
Cash										$ 445,269		445,269			527,346
Trellis Solutions, Inc [Member]
Business Acquisition [Line Items]
Transaction costs																		$ 100,000
Common stock, shares issued | shares																		349,650
Convertible into shares of common stock per share | $ / shares																		$ 7.24
Percentage of exchange rate																		100.00%
Amount of contingent consideration liability																		$ 1
Revenues					$ 216,000
Net income (loss)												$ 17,000
Contingent consideration													$ 0		998,000
Cash																		$ 21
Solo Sciences, Inc. [Member]
Business Acquisition [Line Items]
Transaction costs							$ 300,000
Percentage of exchange rate							80.40%
Description of contingent consideration											(i) $0.01 per solo*TAG™ and solo*CODE™ sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAG™ and solo*CODE™, which is December 1, 2029.
Estimated of fair value contingent consideration							$ 17.9
Revenues						$ 23,000
Net income (loss)						$ 1,500,000
Goodwill and intangible assets impairment											$ 2,700,000
Contingent consideration															389,000
Cash							$ 101
Solo Sciences, Inc. [Member] | Maximum [Member]
Business Acquisition [Line Items]
Percentage of exchange rate										55.00%		55.00%
Solo Sciences, Inc. [Member] | Minimum [Member]
Business Acquisition [Line Items]
Percentage of exchange rate										40.00%		40.00%
Ample Organics [Member]
Business Acquisition [Line Items]
Transaction costs															2,900,000
Revenues											2,600,000
Net income (loss)											100,000
Acquisition of description				acquired 100% of the stock of Ample Organics for 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, $30.7 million was the aggregate value of the exchangeable shares. In addition to the stock consideration, we paid $5.5 million in cash, which was used to settle all of Ample's then outstanding debt. In addition to the stock and cash consideration, the agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition.
Goodwill and intangible assets impairment											$ 4,200,000
Contingent consideration														$ 10,000,000	604,000
Cash				$ 445
Viridian Sciences Inc. [Member]
Business Acquisition [Line Items]
Revenues									$ 2,400,000
Net income (loss)									$ 300,000
Exchange shares value			$ 6,000,000
Contingent consideration			$ 1,000,000												2,000
Cannabis [Member]
Business Acquisition [Line Items]
Contingent consideration															6,300,000
Common stock issued in business combinations	$ 12,000,000
Cash	5,000,000	5,000,000
Aggregate stock price	$ 8,000,000	$ 8,000,000
Viridian [Member]
Business Acquisition [Line Items]
Contingent consideration															$ 2,000
365 Cannabis [Member]
Business Acquisition [Line Items]
Common stock, shares issued | shares	3,600,000	3,600,000
Cash	$ 527	$ 527

Balance Sheet Disclosures (Deta

Balance Sheet Disclosures (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Balance Sheet Disclosures [Abstract]
Software and technology	$ 687,740	$ 480,651
Professional services, dues and subscriptions	546,126	826,195
Insurance	264,097	243,222
Deferred contract costs	260,899	227,718
Unbilled receivable	506,984	612,446
Other	117,918	68,495
Total prepaid expenses and other current assets	$ 2,383,764	$ 2,458,727

Balance Sheet Disclosures (De_2

Balance Sheet Disclosures (Details 1) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Balance Sheet Disclosures [Abstract]
Accounts payable	$ 1,943,457	$ 513,610
Professional fees	319,590	233,667
Sales taxes	360,361	216,367
Compensation	1,123,467	311,379
Contractors	1,288,730	538,618
Settlements and legal	681,045	831,232
Other	346,870	543,703
Total accounts payable, accrued expenses and other current liabilities	$ 6,063,520	$ 3,188,576

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Goodwill [Roll Forward]
Balance at beginning of year	$ 41,874,527	$ 20,254,309
Adjustments to Trellis' goodwill	5,408,884	14,300
Additions due to acquisitions	(14,042,580)	(25,806,518)
Goodwill impairment related to Ample	(14,383,310)	4,172,000
Balance at end of year	$ 46,942,681	$ 41,874,527

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period (in years)	1 year 9 months
Gross carrying amount	$ 25,600,000	$ 11,805,000
Accumulated amortization	(3,990,207)	(1,701,205)
Impairment		(2,715,000)
Total	$ 21,609,793	$ 7,388,795
Acquired developed technology [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period (in years)	3 years 4 months 6 days	3 years 9 months 7 days
Gross carrying amount	$ 7,138,080	$ 8,220,000
Accumulated amortization	(2,815,158)	(1,434,155)
Impairment		(2,591,920)
Total	$ 4,322,922	$ 4,193,925
Acquired trade names [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period (in years)	3 years 1 month 2 days	5 years 1 month 13 days
Gross carrying amount	$ 871,920	$ 705,000
Accumulated amortization	(286,799)	(97,676)
Impairment		(123,080)
Total	$ 585,121	$ 484,244
Customer relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period (in years)	10 years 2 months 4 days	13 years 14 days
Gross carrying amount	$ 17,510,000	$ 2,880,000
Accumulated amortization	(878,250)	(169,374)
Impairment
Total	16,631,750	$ 2,710,626
Non-compete agreement [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	80,000
Accumulated amortization	(10,000)
Impairment
Total	$ 70,000
Capitalized software - In-service [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period (in years)	2 years 7 days	1 year 7 months 13 days
Gross carrying amount	$ 8,807,843	$ 4,593,512
Accumulated amortization	(4,423,887)	(1,401,953)
Impairment
Total	4,383,956	3,191,559
Capitalized software - Work in Progress [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	3,224,203	734,180
Accumulated amortization
Impairment	(296,483)
Total	2,927,720	734,180
Total Capitalized Software [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	12,032,046	5,327,692
Accumulated amortization	(4,423,887)	(1,401,953)
Impairment	(296,483)
Total	7,311,676	3,925,739
Total finite-lived intangible assets [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	37,632,046	17,132,692
Accumulated amortization	(8,414,094)	(3,103,158)
Impairment	(296,483)	(2,715,000)
Total	$ 28,921,469	$ 11,314,534

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net (Details 2)	Dec. 31, 2021USD ($)
Acquired Intangibles Assets [Member]
Finite-Lived Intangible Assets [Line Items]
2022	$ 3,445,741
2023	3,131,575
2024	2,801,991
2025	1,973,934
2026	1,851,434
Thereafter	8,405,118
Total	21,609,793
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
2022	2,722,663
2023	1,144,351
2024	275,884
2025	110,215
2026	59,112
Thereafter	71,731
Total	$ 4,383,956

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2020
Finite-Lived Intangible Assets [Line Items]
Amortization of Intangible Assets	$ 5,600,000	$ 1.8	$ 1,300,000
Weighting to the market approach, percentage	25.00%
Weighted to the income approach, percentage	75.00%
Impairment expense	$ 14,400,000
Impairment Adjustment		$ 4,200,000
Intangible asset charge	14.4
Amortization expense for capitalized software write offs	300,000
Solo [Member]
Finite-Lived Intangible Assets [Line Items]
Impairment of goodwill	$ 2,700,000
Ample Reporting Unit [Member]
Finite-Lived Intangible Assets [Line Items]
Weighting to the market approach, percentage	50.00%
Weighted to the income approach, percentage	50.00%

Fixed assets, net (Details)

Fixed assets, net (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Fixed assets, gross	$ 249,106	$ 1,306,856
Less: accumulated depreciation	(95,955)	(113,423)
Fixed assets, net	153,151	1,193,433
Furniture and computer equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	235,042	131,300
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	$ 14,064	$ 1,175,556

Fixed assets, net (Details Text

Fixed assets, net (Details Textual) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021	Jun. 30, 2020
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 240,742	$ 127,731	$ 27,951
Sale of furniture and computer equipment	25,561
Cost of furniture and computer equipment	191,389
Accumulated depreciation	106,555
Loss on disposals	$ 59,273
Wrote of fixed assets		$ 1,200,000

Investments (Details)

Investments (Details) - USD ($)	Oct. 07, 2019	Dec. 31, 2021	Dec. 31, 2021	Jun. 30, 2020	Jan. 15, 2020
Defined Benefit Plan Disclosure [Line Items]
Convertible into shares of common stock per share					$ 9
Equity loss of investee		$ 12,641	$ 12,641
Revenue recognized		$ 0	$ 25,900	$ 0
Zol Solutions, Inc. [Member]
Defined Benefit Plan Disclosure [Line Items]
Preferred stock purchased shares	203,000
Convertible into shares of common stock per share		$ 1.232	$ 1.232
Preferred stock purchased share value	$ 250,000
Carrying value of our initial investment		$ 226,101	$ 226,101

Long Term Debt (Details)

Long Term Debt (Details)	Dec. 31, 2021USD ($)
Line of Credit Facility [Abstract]
Convertible Notes (at fair value)	$ 17,305,000
Subtotal	17,305,000
Less: current maturities	(13,200,000)
Total long-term debt, less current portion	$ 4,105,000

Long Term Debt (Details 1)

Long Term Debt (Details 1) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Line of Credit Facility [Abstract]
2022	$ 13,200,000
2023	6,800,000
Aggregate maturities	20,000,000
Original issue discount on Convertible Notes	(2,000,000)
Unrealized change in fair value of Convertible Notes	695,000
Total long-term debt, less current portion	17,305,000
Current portion	13,200,000	$ 11,707,363
Noncurrent portion	$ 4,105,000

Long Term Debt (Details Textual

Long Term Debt (Details Textuals) - USD ($)	Oct. 05, 2021	Oct. 05, 2021	Jan. 04, 2021	Jun. 09, 2020	Jun. 08, 2020	Apr. 21, 2020	Dec. 31, 2020	Dec. 31, 2021	Jun. 30, 2020	Sep. 30, 2021	Aug. 31, 2021	Jul. 16, 2020
Debt Instrument [Line Items]
Default interest rate					15.00%
Principal portion of convertible debt	$ 3,300,000	$ 3,300,000		$ 1,000
Original issue discount percentage		10.00%			12.00%
Decrease in convertible debt								$ 30,000	$ 800,000
Instrument-specific credit risk							$ 100,000	20,000
Convertible notes							13,400,000
Convertible notes decreased							13,398,000					$ 14,131,000
Convertible Notes increased							1,000,000	2,000,000
Convertible notes on issuance amount							$ 300,000	$ 10,100,000		$ 2,234,730
Conversion price percentage								80.00%
Conversion price	$ 4,050,000	$ 4,050,000					$ 11.5	$ 4.05
Convertible notes default interest rate of debt										100.00%	100.00%
Original issue discount on holders				$ 880
Face value of the notes	$ 20,000,000	$ 20,000,000			$ 17		$ 1,800,000	$ 15,200,000
Unrealized (loss) gain on convertible notes	0.2						(133,000)	$ 100,000	63,000
Description of loan						the Company issued a promissory note to KeyBank National Association (“KeyBank”) in the principal aggregate amount of $2,204,600 (the “PPP Loan”) pursuant to the Paycheck Protection Program under the CARES Act. The PPP Loan had a two-year term bearing interest at a rate of 1% per annum with principal and interest payments of $92,818 to be paid monthly on the 12th of the month beginning 7 months from the date of the PPP Loan. The PPP Loan provides for prepayment of 20% or less of the unpaid principal balance at any time. If more than 20% is prepaid, then all accrued interest must also be paid.
Conversion price floor								$ 1.92
Other expense							900,000	$ 2,000,000	700,000
Settlement in cash							1,500,000	5,100,000
Installment amount			$ 2,062,500
Decrease in convertible debt								30,000	$ 800,000
Fair value issuance amount								15
Fair value of senior convertible notes							$ 13,398,000					$ 14,131,000
Other Expenses								0.7
Convertible Debt [Member]
Debt Instrument [Line Items]
Principal portion of convertible debt								17.3
Convertible notes decreased								$ 18
Conversion price								$ 11.5
Conversion price floor								$ 0.54
Fair value of senior convertible notes								$ 18
Senior Convertible Notes [Member]
Debt Instrument [Line Items]
Principal portion of convertible debt	$ 14,600,000
Decrease in convertible debt								$ 700,000
Conversion price percentage								80.00%
Decrease in convertible debt								$ 700,000

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2019	Jun. 30, 2019
Shares under warrants
Beginning balance, outstanding		5,813,804
Issued
Exercised
Expired/cancelled
Ending balance, outstanding	5,813,804	5,813,804
Weighted average exercise price
Issued
Exercised
Expired/cancelled
Ending balance, outstanding		$ 11.5	$ 11.5
Weighted average remaining life
Issued
Exercised
Expired/canceled
Balance, outstanding	3 years 4 months 13 days	2 years 11 months 19 days	3 years 11 months 19 days
Aggregate intrinsic value
Issued
Exercised
Expired/cancelled
Balance, outstanding

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual)	Feb. 08, 2018$ / sharesshares	Oct. 30, 2020USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares	Dec. 31, 2021USD ($)$ / sharesshares	Jun. 30, 2020USD ($)	Jan. 15, 2020$ / shares	Jun. 30, 2019USD ($)
Class of Stock [Line Items]
Common stock, shares authorized			75,000,000	75,000,000
Common stock, par value | $ / shares			$ 0.0001	$ 0.0001
Aggregate purchase price of shares | $			$ 327,273	$ 11,610,586
Preferred stock, shares authorized			5,000,000	5,000,000
Preferred stock, par value | $ / shares			$ 0.0001	$ 0.0001
Preferred stock, shares issued			1	1
Preferred stock, shares outstanding			1	1
Common Stock, Voting Rights				one
Purchase price per unit | $ / shares						$ 9
Offering costs from the issuance of common stock | $			$ (967,620)
Aggregate intrinsic value | $			0	0
Balance, outstanding | $
IPO [Member]
Class of Stock [Line Items]
Number of securities called by each warrant or right	1
Common Stock
Class of Stock [Line Items]
Number of classes of stock				1
Preferred stock, shares issued			0
Common Stock | IPO [Member]
Class of Stock [Line Items]
Sale of stock		5,000,000
Purchase price per unit | $ / shares		$ 2.4
Gross proceeds from public offering | $		$ 12,000,000
Offering costs from the issuance of common stock | $		(1,000,000)
Net proceeds from public offering | $		$ 11,000,000
Warrants
Class of Stock [Line Items]
Number of securities called by each warrant or right	1
Exercise price | $ / shares				$ 11.5
Warrants | IPO [Member]
Class of Stock [Line Items]
Sale of stock	5,750,000
Purchase price per unit | $ / shares	$ 10
Warrants | Underwriters [Member]
Class of Stock [Line Items]
Sale of stock	750,000

Stock-Based Compensation (Detai

Stock-Based Compensation (Details 1) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	716,161	827,309
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	100,520	43,906
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	458,270	165,374
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	447,642	429,974
Summary of unvested Restricted Shares and RSUs activity
Beginning balance, unvested	827,309	606,615
Granted	447,642	429,974
Vested	(458,270)	(165,374)
Forfeited	(100,520)	(43,906)
Ending balance, unvested	716,161	827,309
Summary of unvested Restricted Shares and RSUs, Weighted Average Grant Date Fair Value
Beginning balance, outstanding	$ 6.77	$ 6.56
Granted		4.88
Vested		5.08
Forfeited		6.83
Ending balance, outstanding		$ 6.77
Restricted Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	32,394	64,289
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	1,336
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	30,559	8,024
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Summary of unvested Restricted Shares and RSUs activity
Beginning balance, unvested	64,289	72,313
Granted
Vested	(30,559)	(8,024)
Forfeited	(1,336)
Ending balance, unvested	32,394	64,289
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number		763,020
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period		43,906
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		157,350
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		429,974
Summary of unvested Restricted Shares and RSUs activity
Beginning balance, unvested	763,020	534,302
Granted		429,974
Vested		(157,350)
Forfeited		(43,906)
Ending balance, unvested		763,020
Summary of unvested Restricted Shares and RSUs, Weighted Average Grant Date Fair Value
Granted	$ 447,642
Vested	427,711
Forfeited	99,184
Ending balance, outstanding	$ 683,767

Stock-Based Compensation (Det_2

Stock-Based Compensation (Details Textual) - USD ($)	1 Months Ended	6 Months Ended	9 Months Ended	12 Months Ended
	Jun. 26, 2020	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2021	Jun. 30, 2020	Jun. 17, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized			$ 2
Compensation cost capitalized		$ 0.2
Restricted Shares and Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized				$ 2	$ 1.3
Compensation cost capitalized				0.04	$ 0.1
Unrecognized compensation costs				$ 3.7
Estimated weighted average remaining vesting period				2 years 4 months 28 days
Restricted Shares and Restricted Stock Units [Member] | Equity Incentive Plan [Member] | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved	1,565,038					1,040,038
Shares authorized for issuance	525,000
Restricted Stock Units [Member] | Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period from the grant date or the first day of the service period				4 years
Profits Interest Units | Profits Interest Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period from the grant date or the first day of the service period				4 years
Stock-based compensation expense recognized				$ 3.4

Loss Per Share (Details)

Loss Per Share (Details) - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Fully diluted	19,323,646	10,559,322
Shares issuable upon exchange of Exchangeable Shares [Member]
Class of Stock [Line Items]
Fully diluted	309,286	2,667,349
Shares of common stock issuable in upon conversion of Convertible Notes [Member]
Class of Stock [Line Items]
Fully diluted	12,484,395	1,319,368
Warrants [Member]
Class of Stock [Line Items]
Fully diluted	5,813,804	5,813,804
Restricted Stock Units [Member]
Class of Stock [Line Items]
Fully diluted	683,767	694,512
Restricted Stock Awards [Member]
Class of Stock [Line Items]
Fully diluted	32,394	64,289

Fair Value (Details)

Fair Value (Details) - USD ($)	3 Months Ended	6 Months Ended	9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Oct. 05, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Beginning fair value balance on issue date
Payments on Convertible Notes		$ (1,827,273)	$ (15,172,727)
Change in fair value reported in the statements of operations		961,273	2,030,904
Change in fair value reported in other comprehensive income		133,000	70,000
Gain on extinguishment of debt reported on the statement of operations			186,177
Ending fair value balance		$ 13,398,000
Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Beginning fair value balance on issue date	18,000,000
Payments on Convertible Notes
Change in fair value reported in the statements of operations	665,000
Change in fair value reported in other comprehensive income	30,000
Ending fair value balance	$ 17,305,000		$ 18,000,000

Fair Value (Details 1)

Fair Value (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Oct. 05, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Face value principal payable	$ 20,000,000	$ 15,172,272
Original conversion price	$ 4.05	$ 11.5	$ 4,050,000
Value of Common Stock	$ 1.75	$ 3.24
Expected term (years)	2 years 9 months 18 days	2 years 3 months 18 days
Volatility	75.00%	77.00%
Market yield (range)	37.10%
Risk free rate	1.00%	0.10%
Issue date	Oct. 5, 2021	Jun. 9, 2020
Maturity date	Oct. 5, 2024	Jun. 1, 2023
Minimum [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Market yield (range)		27.10%
Maximum [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Market yield (range)		27.20%

Fair Value (Details 3)

Fair Value (Details 3) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of Private Warrants	5,813,804	5,813,804	5,813,804
Value of Common Stock	$ 1.75	$ 3.24
Expected term (years)	2 years 9 months 18 days	2 years 3 months 18 days
Volatility	75.00%	77.00%
Risk free rate	1.00%	0.10%
Private Warrants [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of Private Warrants	225,635	225,635
Warrant exercised price	$ 11.5	$ 11.5
Value of Common Stock	$ 1.75	$ 3.24
Expected term (years)	2 years 5 months 15 days	3 years 5 months 15 days
Volatility	85.80%	102.30%
Risk free rate	0.80%	0.20%

Fair Value (Details 2)

Fair Value (Details 2) - Private Warrants [Member] - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Fair value balance at beginning of period	$ 311,376	$ 688,187
Change in fair value reported in the statements of operations	(248,198)	(376,811)
Fair value balance at end of period	$ 63,178	$ 311,376

Fair Value (Details Textual)

Fair Value (Details Textual)

Jul. 07, 2020USD ($)

Apr. 08, 2020USD ($)$ / shares

Dec. 31, 2021CAD ($)

Dec. 31, 2021USD ($)

Dec. 31, 2020USD ($)shares

Dec. 31, 2021USD ($)$ / shares

Oct. 05, 2021USD ($)

Oct. 30, 2020$ / shares

Sep. 01, 2020shares

Jun. 30, 2020USD ($)

Jun. 09, 2020USD ($)

Jan. 15, 2020$ / shares

Feb. 08, 2018$ / sharesshares

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Principal amount

$ 20,000,000

$ 17

Fair value of the contingent consideration

$ 6,300,000

Purchase price

$ 18,000,000

$ 15

Settled value of the contingent consideration

$ 0

Gain on settlement of the contingent consideration liability

$ 998,000

Purchase price per unit | $ / shares

$ 9

Shares sold | shares

309,286

4,798,271

Exchange ratio of converted warrants upon conversion

1.00%

1.00%

IPO [Member]

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Number of securities called by each warrant or right | shares

1

Common Stock [Member]

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Number of shares issued | shares

189,365

Common Stock [Member] | IPO [Member]

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Purchase price per unit | $ / shares

$ 2.4

Warrant [Member]

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Exercise price | $ / shares

$ 11.5

Number of securities called by each warrant or right | shares

1

Warrant [Member] | IPO [Member]

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Purchase price per unit | $ / shares

$ 10

Trellis Solutions, Inc [Member]

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Fair value of the contingent consideration

$ 998,000

$ 0

Settled value of the contingent consideration

$ 3,529

Purchase price per unit | $ / shares

$ 7.24

Solo Sciences, Inc. [Member]

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Description of contingent consideration

(i) $0.01 per solo*TAGTM and solo*CODETM sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAGTM and solo*CODETM, which is December 1, 2029.

(i) $0.01 per solo*TAGTM and solo*CODETM sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAGTM and solo*CODETM, which is December 1, 2029.

Fair value of the contingent consideration

389,000

Settled value of the contingent consideration

$ 17,939

$ 0

Gain on settlement of the contingent consideration liability

$ 389,000

Ample Organics [Member]

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Description of contingent consideration

The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000and the amount of Recurring Revenue realized during the twelve months following the acquisition.

The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000and the amount of Recurring Revenue realized during the twelve months following the acquisition.

Fair value of the contingent consideration

$ 10,000,000

$ 604,000

Settled value of the contingent consideration

$ 31,531

$ 0

Gain on settlement of the contingent consideration liability

$ 604,000

Recurring revenue recognized

$ 9,000,000

Mtech [Member]

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Number of securities called by each warrant or right | shares

1

Mtech [Member] | IPO [Member]

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Number of shares issued | shares

5,750,000

Purchase price per unit | $ / shares

$ 10

Shares sold | shares

750,000

Exercise price | $ / shares

$ 11.5

Mtech [Member] | Private Placement [Member]

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Purchase price per unit | $ / shares

$ 10

Shares sold | shares

243,750

Exercise price | $ / shares

$ 11.5

Mtech [Member] | Common Stock [Member]

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Number of securities called by each warrant or right | shares

1

Commitments and Contingencies_2

Commitments and Contingencies (Details)	Dec. 31, 2021USD ($)
Commitments and Contingencies Disclosure [Abstract]
2022	$ 252,525
2023	260,100
2024	110,480
Total	$ 623,105

Commitments and Contingencies_3

Commitments and Contingencies (Details Textual) - USD ($)	Dec. 04, 2020	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2020	Sep. 30, 2021	Apr. 02, 2021	Nov. 23, 2020
Short-term Debt [Line Items]
Rent expense		$ 552,861	$ 157,593		$ 299,629
Future minimum lease payments two years			252,525
security deposit			41,250
Termination fee			402,480			$ 980,000
Assets written off			$ 1,045,209
Common stock issued for cash consideration			556,388
Share price			$ 3.55
Issued and outstanding shares percentage								5.00%
TechMagic USA LLC [Member]
Short-term Debt [Line Items]
Recovery amount	$ 1,070,000
Litigation amount	$ 787,000
Loss contingency			$ 500,000	$ 600,000
TreCom Systems Group Inc [Member]
Short-term Debt [Line Items]
Recovery amount							$ 2,000,000
Loss contingency			$ 200,000	0
Denver, CO. [Member]
Short-term Debt [Line Items]
Common stock issued for cash consideration			113,375
Line of Credit [Member]
Short-term Debt [Line Items]
Restricted cash		500,000		500,000
Letter-of-credit with a bank		$ 500,000	$ 500,000	$ 500,000

Income Taxes (Details)

Income Taxes (Details) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2020
Current income taxes
U.S. federal				$ 30,985
U.S. state	200	5,800
Foreign		6,270
Total current income taxes	$ 200	12,070		30,985
Deferred income taxes
U.S. federal		2,274,295
U.S. state
Total deferred income tax benefit		$ 2,274,295

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2020
Income tax expense and rate attributable to:
Federal		$ (6,692,267)	$ (3,560,998)	$ (3,255,706)
State, net of federal benefit		(672,148)	(553,871)	(862,690)
Foreign tax rate less than federal rate		(138,292)	29,617	(2,645)
Permanent differences		2,428,631	1,263,151	312,525
Rate change		54,295	60,220
Changes in valuation allowance		3,361,603	2,762,081	3,884,440
Provision to return adjustment		273,489		(45,134)
Losses from flow-through entity not subject to tax
Deferred True-Ups		(928,743)
Other adjustments		51,207		195
Effective income tax expense	$ 200	$ (2,262,225)		$ 30,985

Income Taxes (Details 2)

Income Taxes (Details 2) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2020
Noncurrent deferred tax assets:
Employee compensation	$ 820,410	$ 679,106
Debt issuance costs	138,778	343,612
Revenue recognition	105,735
Settlement accrual	146,604	182,896
Fixed assets	242,006	831,196
Federal and state net operating loss	10,673,908	6,337,897
Foreign net operating loss	4,904,857	2,586,671
Other	225,340	27,410
Total deferred tax assets	17,257,638	10,988,788
Noncurrent deferred tax liabilities:
Fixed assets
Intangibles	(6,051,459)	(2,717,717)
Deferred tax liabilities	(6,051,459)	(2,717,717)
Valuation allowance	(11,881,470)	(8,271,071)
Deferred taxes after valuation allowance	$ 675,291

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021	Jun. 30, 2020	Apr. 30, 2020
Income Tax Disclosure [Abstract]
Net operating losses		$ 44,500,000
Change in valuation allowance	$ 5,500,000	3,600,000
Uncertain tax position		30,000	$ 50,000
Valuation allowance	8,271,071	$ 11,881,470
Income taxes, description		We have deferred tax assets related to foreign net operating loss carryforward, which begin to expire in 2034, in the amount of $18.5 million.
Aggregate amount of loan				$ 2,200,000
Purchase price	2,700,000	$ 200,000
Deferred expense	$ 2,800,000	$ 3,400,000

Revisions of Previously Issue_3

Revisions of Previously Issued Financial Statements (Details) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021	Jun. 30, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss per share	$ (1.01)	$ (1.22)	$ (1.14)
As Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Change in fair value of derivative liability
Net loss attributable to Akerna shareholders	$ (16,957,334)		$ (15,534,345)
Net loss per share	$ (1.01)		$ (1.31)
Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Change in fair value of derivative liability	$ 746,852		$ 1,962,034
Net loss attributable to Akerna shareholders	$ 746,852		$ 1,962,034
Net loss per share
As Revised [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Change in fair value of derivative liability	$ 746,852		$ 1,962,034
Net loss attributable to Akerna shareholders	$ (16,210,482)		$ (13,572,311)
Net loss per share	$ (1.01)		$ (1.14)

Revisions of Previously Issue_4

Revisions of Previously Issued Financial Statements (Details 1) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Jul. 02, 2020
Derivative liability	$ 63,178	$ 311,376
Total liabilities	34,533,484	19,946,452
Additional paid-in capital	146,027,258	94,086,433
Accumulated deficit	$ (88,508,236)	(57,179,525)	$ 0.2
As Reported [Member]
Derivative liability
Total liabilities		19,635,076
Additional paid-in capital		95,090,833
Accumulated deficit		(57,872,599)
Adjustment [Member]
Derivative liability		(311,376)
Total liabilities		(311,376)
Additional paid-in capital		(1,004,450)
Accumulated deficit		(693,074)
As Revised [Member]
Derivative liability		(311,376)
Total liabilities		19,946,452
Additional paid-in capital		(94,086,433)
Accumulated deficit		$ (57,179,525)